Target (6)
Compound (720)
Article Title (10)
Assay (261)
Lopez, S; Simons, SS Dexamethasone 21-(beta-isothiocyanatoethyl) thioether: a new affinity label for glucocorticoid receptors. J Med Chem 34: 1762 -7 (1991) Burkhart, JP; Koehl, JR; Mehdi, S; Durham, SL; Janusz, MJ; Huber, EW; Angelastro, MR; Sunder, S; Metz, WA; Shum, PW Inhibition of human neutrophil elastase. 3. An orally active enol acetate prodrug. J Med Chem 38: 223 -33 (1995) Smith, ME; Gunn, RM; Rosivatz, E; Mak, LH; Woscholski, R; Hailes, HC Development of chemical probes: toward the mode of action of a methylene-linked di(aryl acetate) E1. Bioorg Med Chem 18: 4917 -27 (2010) Innocenti, A; Supuran, CT Paraoxon, 4-nitrophenyl phosphate and acetate are substrates ofa- but not ofß-,¿- and¿-carbonic anhydrases. Bioorg Med Chem Lett 20: 6208 -12 (2010) Duan, YT; Sang, YL; Makawana, JA; Teraiya, SB; Yao, YF; Tang, DJ; Tao, XX; Zhu, HL Discovery and molecular modeling of novel 1-indolyl acetate--5-nitroimidazole targeting tubulin polymerization as antiproliferative agents. Eur J Med Chem 85: 341 -51 (2014) Wen, H; Zhou, Y; Lin, C; Ge, H; Ma, L; Wang, Z; Peng, W; Song, H Methyl 2-(2-(4-formylphenoxy)acetamido)-2-substituted acetate derivatives: a new class of acetylcholinesterase inhibitors. Bioorg Med Chem Lett 17: 2123 -5 (2007) Whitehead, L; Dobler, MR; Radetich, B; Zhu, Y; Atadja, PW; Claiborne, T; Grob, JE; McRiner, A; Pancost, MR; Patnaik, A; Shao, W; Shultz, M; Tichkule, R; Tommasi, RA; Vash, B; Wang, P; Stams, T Human HDAC isoform selectivity achieved via exploitation of the acetate release channel with structurally unique small molecule inhibitors. Bioorg Med Chem 19: 4626 -34 (2011) Sultan, S; Choudhary, MI; Khan, SN; Fatima, U; Atif, M; Ali, RA; Rahman, AU; Fatmi, MQ Fungal transformation of cedryl acetate anda-glucosidase inhibition assay, quantum mechanical calculations and molecular docking studies of its metabolites. Eur J Med Chem 62: 764 -70 (2013) Wambua, MK; Nalawansha, DA; Negmeldin, AT; Pflum, MK Mutagenesis studies of the 14 Å internal cavity of histone deacetylase 1: insights toward the acetate-escape hypothesis and selective inhibitor design. J Med Chem 57: 642 -50 (2014) Silva-Ortiz, AV; Bratoeff, E; Ram?rez-Apan, T; Heuze, Y; S?nchez, A; Soriano, J; Cabeza, M Synthesis and activity of novel 16-dehydropregnenolone acetate derivatives as inhibitors of type 1 5a-reductase and on cancer cell line SK-LU-1. Bioorg Med Chem 23: 7535 -42 (2015)
ChEMBL_312086 Inhibition of glucocorticoid receptor Dexamethasone response ChEMBL_71247 Inhibition of Dexamethasone binding to Glucocorticoid receptor ChEMBL_726913 Displacement of radiolabeled Dexamethasone from GR ChEMBL_728108 Displacement of radiolabeled Dexamethasone from GR ChEBML_71399 Displacement of Dexamethasone from human glucocorticoid receptor ChEMBL_305896 Inhibition of [3H]dexamethasone binding to glucocorticoid receptor ChEMBL_372312 Inhibition of fluorescent-labeled Dexamethasone binding to GR ChEMBL_437577 Displacement of radiolabeled Dexamethasone from human GR ChEMBL_447642 Displacement of radiolabeled Dexamethasone from glucocorticoid receptor ChEMBL_479540 Displacement of radiolabeled Dexamethasone from glucocorticoid receptor ChEMBL_71405 Displacement of [3H]- Dexamethasone from glucocorticoid receptor ChEBML_123499 Displacement of [3H]dexamethasone from human mineralocorticoid receptor ChEBML_159372 Displacement of [3H]dexamethasone from human progesterone receptor ChEBML_36109 Displacement of [3H]dexamethasone from human androgen receptor ChEMBL_305404 Inhibition of [3H]dexamethasone binding to human glucocorticoid receptor ChEMBL_305749 Inhibition of [3H]dexamethasone binding to human glucocorticoid receptor ChEMBL_440116 Displacement of [3H]dexamethasone from human recombinant GR ChEMBL_452405 Displacement of fluorescent labeled Dexamethasone from glucocorticoid receptor ChEMBL_466158 Displacement of [3H]dexamethasone from human recombinant GR ChEMBL_558475 Displacement of fluorescent labelled Dexamethasone from glucocorticoid receptor ChEMBL_71383 Inhibition of [3H]dexamethasone binding to human Glucocorticoid Receptor ChEMBL_71413 Inhibition of [3H]dexamethasone binding to human Glucocorticoid Receptor ChEMBL_716755 Displacement of fluorescent-labelled Dexamethasone from glucocorticoid receptor ChEMBL_1510389 Antagonist activity against glucocorticoid receptor in rat H4-IIE cells assessed as inhibition of dexamethasone-induced receptor transactivation pre-incubated for 1 hr before dexamethasone addition and measured 24 hrs post dexamethasone stimulation by tyrosine aminotransferase enzyme assay ChEMBL_306249 Inhibition of human glucocorticoid receptor alpha by displacement of [3H]dexamethasone ChEMBL_312728 Inhibition of glucocorticoid receptor Dexamethasone response in reporter gene assay ChEMBL_423016 Inhibition of tetramethylrhodamine labeled dexamethasone binding to GR by FP assay ChEMBL_423018 Inhibition of tetramethylrhodamine labeled dexamethasone binding to MR by FP assay ChEMBL_447639 Agonist activity at GR by GRE activation assay relative to Dexamethasone ChEMBL_701245 Displacement of radiolabeled Dexamethasone from glucocorticoid receptor expressed in baculovirus ChEMBL_71101 Displacement of [3H]dexamethasone from human Glucocorticoid receptor (GR) ChEMBL_739803 Displacement of radiolabeled Dexamethasone from glucocorticoid receptor expressed in baculovirus ChEMBL_1559801 Displacement of [3H]dexamethasone from glucocorticoid receptor in human IM9 cells ChEMBL_1633608 Displacement of [3H]dexamethasone from GR receptor in human IM9 cells ChEMBL_1735710 Antagonist activity at human GR assessed as reduction in dexamethasone-induced transactivation ChEMBL_312773 Inhibition of dexamethasone-induced glucocorticoid receptor mediated alkaline phosphatase activity ChEMBL_447640 Antagonist activity at GR assessed as inhibition of dexamethasone-induced GRE activation ChEMBL_448942 Displacement of TAMRA labeled Dexamethasone at human glucocorticoid receptor in insect cell ChEMBL_448943 Displacement of TAMRA labeled Dexamethasone at human progesterone receptor in insect cell ChEMBL_634771 Displacement of fluorescent-labeled Dexamethasone from GR by fluorescent polarization assay ChEMBL_71395 Displacement of 10 nM [3H]dexamethasone from human Glucocorticoid receptor ChEMBL_71396 Displacement of 10 nM [3H]dexamethasone from human Glucocorticoid receptor ChEMBL_71397 Binding affinity towards glucocorticoid receptor (GR) by displacing [3H]dexamethasone ChEMBL_1700184 Antagonist activity at rat glucocorticoid receptor in primary hepatocytes assessed as dexamethasone-induced tyrosine amino transferase activity preincubated for 30 mins followed by dexamethasone addition measured after 20 hrs ChEMBL_1700185 Antagonist activity at dog glucocorticoid receptor in primary hepatocytes assessed as dexamethasone-induced tyrosine amino transferase activity preincubated for 30 mins followed by dexamethasone addition measured after 20 hrs ChEBML_71420 Competitive displacement of [3H]dexamethasone from glucocorticoid receptor of rat liver cytosol ChEMBL_1292840 Displacement of [3H]-dexamethasone from human glucocorticoid receptor expressed in HEK293 cells ChEMBL_306508 Inhibition of dexamethasone-induced glucocorticoid receptor mediated tyrosine aminotransferase in rat hepatocytes ChEMBL_457478 Displacement of [3H]dexamethasone from human glucocorticoid receptor expressed in recombinant baculovirus ChEMBL_70937 Inhibition of Dexamethasone stimulated transcriptional activity in CHO cells expressing glucocorticoid receptor ChEMBL_70938 Inhibition of Dexamethasone stimulated transcriptional activity in CHO cells expressing glucocorticoid receptor ChEMBL_1700170 Antagonist activity at glucocorticoid receptor in human HepG2 cells assessed as inhibition of dexamethasone-induced tyrosine amino transferase activity preincubated for 30 mins followed by dexamethasone addition measured after 20 hrs ChEMBL_1700218 Antagonist activity at glucocorticoid receptor in human primary hepatocytes assessed as inhibition of dexamethasone-induced tyrosine amino transferase activity preincubated for 30 mins followed by dexamethasone addition measured after 20 hrs ChEMBL_839721 Antagonist activity at glucocorticoid receptor in rat hepatocytes assessed as inhibition of dexamethasone-induced trypsine aminotransferase expression incubated for 30 mins prior to dexamethasone-induction measured after 4 hrs by reporter gene assay ChEBML_71100 Binding affinity against human Glucocorticoid receptor (GR) using [3H]dexamethasone as radioligand ChEMBL_1446326 Displacement of tetramethylrhodamine-labeled dexamethasone from PR (unknown origin) by fluorescence polarization assay ChEMBL_199711 Transcriptional repression activity in HEP G2 cells expressing glucocorticoid receptor compared to Dexamethasone ChEMBL_306509 Inhibition of dexamethasone-induced GR-mediated tyrosine amino transferase activity in rat hepatocytes ChEMBL_71100 Binding affinity against human Glucocorticoid receptor (GR) using [3H]dexamethasone as radioligand ChEMBL_71400 Inhibition of Dexamethasone binding to human glucocorticoid receptor expressed in baculovirus SF-12 cells ChEMBL_71401 Displacement of Dexamethasone from human glucocorticoid receptor expressed in baculovirus SF-12 cells ChEMBL_726895 Displacement of [3H]dexamethasone from Sprague-Dawley rat GR by liquid scintillation counting ChEMBL_1338546 Displacement of TAMRA-labeled dexamethasone from glucocorticoid receptor (unknown origin) by fluorescence polarization assay ChEMBL_1338548 Displacement of TAMRA-labeled dexamethasone from mineralocorticoid receptor (unknown origin) by fluorescence polarization assay ChEMBL_199710 Transcriptional repression of IL-1 stimulated IL-6 expression in native cells compared to Dexamethasone ChEMBL_466159 Antagonist activity at GR in SW1353/MMTV5 cells assessed as inhibition of dexamethasone-induced luciferase expression ChEMBL_499970 Displacement of FITC-dexamethasone from human recombinant glucocorticoid receptor alpha by fluorescence polarization assay ChEMBL_637924 Displacement of [3H]dexamethasone from human glucocorticoid receptor after 16 hrs by scintillation counting ChEMBL_849777 Displacement of [3H]-dexamethasone from human full length GR expressed in insect Sf21 cells ChEMBL_965461 Displacement of [3H]Dexamethasone from glucocorticoid receptor in human HeLaS3 cells after 2 hrs ChEMBL_1499884 Displacement of [3H]-dexamethasone from cytosolic fraction of human recombinant glucocorticoid receptor by scintillation counting analysis ChEMBL_1620823 Displacement of [3H]dexamethasone from human GR measured after 18 hrs by scintillation counting method ChEMBL_1864065 Displacement of [3H]dexamethasone from recombinant human GR after 360 mins by scintillation counting analysis ChEMBL_873662 Displacement of [3H]dexamethasone from human glucocorticoid receptor overexpressed in HEK293 cells by microbeta counting assay ChEMBL_977683 Displacement of [3H]-Dexamethasone human GR expressed in 293 cells after 16 hrs by scintillation counting ChEBML_71109 Displacement of [3H]dexamethasone from human Glucocorticoid receptor (GR); Value ranges from 150-220 nM ChEMBL_1277677 Displacement of TAMRA-labeled dexamethasone from glucocorticoid receptor (unknown origin) by fluorescence polarization competitive binding assay ChEMBL_1827551 Displacement of [3H]dexamethasone from GR in human IM9 cells after 6 hrs by scintillation counting method ChEMBL_424794 Activity at GR expressed in CHO cells assessed as decrease in dexamethasone-stimulated alkaline phosphatase production by GRAF assay ChEMBL_71102 Displacement of [3H]dexamethasone from human Glucocorticoid receptor (GR); Value ranges from 10-12 nM ChEMBL_71103 Displacement of [3H]dexamethasone from human Glucocorticoid receptor (GR); Value ranges from 106-131 nM ChEMBL_71104 Displacement of [3H]dexamethasone from human Glucocorticoid receptor (GR); Value ranges from 1273-2947 nM ChEMBL_71105 Displacement of [3H]dexamethasone from human Glucocorticoid receptor (GR); Value ranges from 13-26 nM ChEMBL_71106 Displacement of [3H]dexamethasone from human Glucocorticoid receptor (GR); Value ranges from 133-161 nM ChEMBL_71107 Displacement of [3H]dexamethasone from human Glucocorticoid receptor (GR); Value ranges from 1382-1049 nM ChEMBL_71108 Displacement of [3H]dexamethasone from human Glucocorticoid receptor (GR); Value ranges from 1428-1433 nM ChEMBL_71109 Displacement of [3H]dexamethasone from human Glucocorticoid receptor (GR); Value ranges from 150-220 nM ChEMBL_71110 Displacement of [3H]dexamethasone from human Glucocorticoid receptor (GR); Value ranges from 159-161 nM ChEMBL_71111 Displacement of [3H]dexamethasone from human Glucocorticoid receptor (GR); Value ranges from 17-21 nM ChEMBL_71112 Displacement of [3H]dexamethasone from human Glucocorticoid receptor (GR); Value ranges from 2-2 nM ChEMBL_71113 Displacement of [3H]dexamethasone from human Glucocorticoid receptor (GR); Value ranges from 215-217 nM ChEMBL_71114 Displacement of [3H]dexamethasone from human Glucocorticoid receptor (GR); Value ranges from 23-33 nM ChEMBL_71115 Displacement of [3H]dexamethasone from human Glucocorticoid receptor (GR); Value ranges from 26-67 nM ChEMBL_71116 Displacement of [3H]dexamethasone from human Glucocorticoid receptor (GR); Value ranges from 28-34 nM ChEMBL_71117 Displacement of [3H]dexamethasone from human Glucocorticoid receptor (GR); Value ranges from 294-554 nM ChEMBL_71118 Displacement of [3H]dexamethasone from human Glucocorticoid receptor (GR); Value ranges from 3-3 nM ChEMBL_71228 Displacement of [3H]dexamethasone from human Glucocorticoid receptor (GR); Value ranges from 3-4 nM ChEMBL_71229 Displacement of [3H]dexamethasone from human Glucocorticoid receptor (GR); Value ranges from 366-578 nM ChEMBL_71230 Displacement of [3H]dexamethasone from human Glucocorticoid receptor (GR); Value ranges from 378-814 nM ChEMBL_71231 Displacement of [3H]dexamethasone from human Glucocorticoid receptor (GR); Value ranges from 379-840 nM ChEMBL_71232 Displacement of [3H]dexamethasone from human Glucocorticoid receptor (GR); Value ranges from 39-94 nM ChEMBL_71233 Displacement of [3H]dexamethasone from human Glucocorticoid receptor (GR); Value ranges from 43-50 nM ChEMBL_71234 Displacement of [3H]dexamethasone from human Glucocorticoid receptor (GR); Value ranges from 44-53 nM ChEMBL_71235 Displacement of [3H]dexamethasone from human Glucocorticoid receptor (GR); Value ranges from 5-6 nM ChEMBL_71236 Displacement of [3H]dexamethasone from human Glucocorticoid receptor (GR); Value ranges from 536-560 nM ChEMBL_71237 Displacement of [3H]dexamethasone from human Glucocorticoid receptor (GR); Value ranges from 559-1423 nM ChEMBL_71238 Displacement of [3H]dexamethasone from human Glucocorticoid receptor (GR); Value ranges from 6-7 nM ChEMBL_71239 Displacement of [3H]dexamethasone from human Glucocorticoid receptor (GR); Value ranges from 6-8 nM ChEMBL_71240 Displacement of [3H]dexamethasone from human Glucocorticoid receptor (GR); Value ranges from 61-63 nM ChEMBL_71241 Displacement of [3H]dexamethasone from human Glucocorticoid receptor (GR); Value ranges from 639-673 nM ChEMBL_71242 Displacement of [3H]dexamethasone from human Glucocorticoid receptor (GR); Value ranges from 681-974 nM ChEMBL_71243 Displacement of [3H]dexamethasone from human Glucocorticoid receptor (GR); Value ranges from 70-92 nM ChEMBL_71244 Displacement of [3H]dexamethasone from human Glucocorticoid receptor (GR); Value ranges from 838-988 nM ChEMBL_71245 Displacement of [3H]dexamethasone from human Glucocorticoid receptor (GR); Value ranges from 9-12 nM ChEMBL_71246 Displacement of [3H]dexamethasone from human Glucocorticoid receptor (GR); Value ranges from 949-1169 nM ChEMBL_772901 Displacement of [3H]-dexamethasone from human recombinant glucocorticoid receptor after 18 hrs by liquid scintillation counting ChEMBL_372315 Activity at GR assessed as ability to antagonize dexamethasone-induced MMTV luciferase reporter gene transactivation in human A549 cells ChEMBL_372316 Agonist activity at GR assessed as MMTV-mediated transactivation of renilla luciferase gene in human A549 cells relative to Dexamethasone ChEMBL_479545 Antagonist activity at glucocorticoid receptor assessed as inhibition of dexamethasone-induced glucose response element transcriptional transactivation by luciferase assay ChEMBL_71398 Binding affinity towards human glucocorticoid receptor (GR) was determined using [3H]dexamethasone as radioligand in SF-1 cells ChEMBL_728113 Agonist activity at human GR expressed in NHDF cells assessed as inhibition of IL-6 production by ELISA relative to Dexamethasone ChEMBL_89092 Repression activity of GR ligand with interleukin-6 receptor in native cell assay using Dexamethasone was determined as maximal potency ChEMBL_1438889 Displacement of [3H]-Dexamethasone from glucocorticoid receptor (unknown origin) expressed in 293 cells after 16 hrs by scintillation counting ChEMBL_2111613 Displacement of [3H]dexamethasone from glucocorticoid receptor in human IM-9 cells incubated for 6 hrs by scintillation counting analysis ChEMBL_841250 Displacement of fluorescent labelled SRC1-4 from dexamethasone-GR complex after 2 to 4 hrs by TR-FRET assay ChEMBL_886649 Displacement of [3H]dexamethasone from human recombinant glucocorticoid receptor expressed in baculovirus after 18 hrs by scintillation counting analysis ChEMBL_936982 Displacement of [3H]-dexamethasone human glucocorticoid receptor alpha expressed in 293 MSR cells after 60 mins by scintillation counting ChEMBL_362836 Inhibition of human CA2 by 4-nitrophenyl acetate hydrolysis ChEMBL_1510382 Displacement of [3H]-dexamethasone from human glucocorticoid receptor expressed in HEK293 cells by scintillation counting based radioligand competition binding assay ChEMBL_1755053 Displacement of [3H]dexamethasone from human recombinant glucocorticoid receptor expressed in insect cells after 24 hrs by scintillation proximity assay ChEMBL_2172765 Antagonist activity at glucocorticoid receptor in human HeLa cells assessed as reduction in dexamethasone-induced luciferase activity by dual-Glo luciferase assay ChEMBL_321122 Effective concentration against inhibition of Dexamethasone induced glucocorticoid receptor transactivation of mouse mammary tumor virus luciferase gene in HeLa cells ChEMBL_448641 Antagonist activity at glucocorticoid receptor in human A549 cells transfected with MMTV luciferase reporter gene assessed as inhibition of dexamethasone-induced activation ChEMBL_452410 Antagonist activity at glucocorticoid receptor in human A549 cells transfected with MMTV luciferase reporter gene assessed as inhibition of dexamethasone-induced activation ChEMBL_457479 Antagonist activity at human glucocorticoid receptor in SW1353 cells assessed as inhibition of dexamethasone-induced luciferase expression by MMTV5 reporter gene assay ChEMBL_663368 Binding affinity to glucocorticoid receptor expressed in baculovirus-infected insect cells using tetramethylrhodamine labeled Dexamethasone by fluorescence polarization microplate assay ChEMBL_663370 Binding affinity to mineralocorticoid receptor expressed in baculovirus-infected insect cells using tetramethylrhodamine labeled Dexamethasone by fluorescence polarization microplate assay ChEMBL_775646 Displacement of tetramethylrhodamine-labeled Dexamethasone from human recombinant glucocorticoid receptor expressed in baculovirus infected insect cells by fluorescence polarization assay ChEMBL_775648 Displacement of tetramethylrhodamine-labeled Dexamethasone from human recombinant mineralocorticoid receptor expressed in baculovirus infected insect cells by fluorescence polarization assay ChEMBL_839719 Displacement of [3H]dexamethasone from human glucocorticoid receptor expressed in baculovirus infected Sf9 cells after overnight incubation by scintillation counting ChEMBL_1275505 Displacement of [3H]dexamethasone from GST-tagged human glucocorticoid receptor ligand binding domain after 4 hrs by liquid scintillation counting ChEMBL_1553954 Displacement of [3H]-dexamethasone from glucocorticoid receptor (unknown origin) expressed in HEK293 cell lysate incubated overnight by microbeta scintillation counting method ChEMBL_1678021 Displacement of [3H]-dexamethasone from recombinant human GST-tagged GR ligand binding domain after 4 hrs by liquid scintillation counting ChEMBL_1736302 Antagonist activity at GR in human PBMC assessed as reduction in dexamethasone-induced GILZ gene expression incubated for 6 hrs by RT-qPCR method ChEMBL_1736303 Antagonist activity at GR in human PBMC assessed as reduction in dexamethasone-induced FKBP5 gene expression incubated for 6 hrs by RT-qPCR method ChEMBL_1736304 Antagonist activity at GR in rat PBMC assessed as reduction in dexamethasone-induced GILZ gene expression incubated for 24 hrs by RT-qPCR method ChEMBL_1736305 Antagonist activity at GR in rat PBMC assessed as reduction in dexamethasone-induced FKBP5 gene expression incubated for 24 hrs by RT-qPCR method ChEMBL_1736306 Antagonist activity at GR in dog PBMC assessed as reduction in dexamethasone-induced GILZ gene expression incubated for 6 hrs by RT-qPCR method ChEMBL_1736307 Antagonist activity at GR in dog PBMC assessed as reduction in dexamethasone-induced FKBP5 gene expression incubated for 6 hrs by RT-qPCR method ChEMBL_1736312 Antagonist activity at GR in human OVCAR5 assessed as reduction in dexamethasone-induced GILZ gene expression incubated for 24 hrs by RT-qPCR method ChEMBL_1736313 Antagonist activity at GR in human OVCAR5 assessed as reduction in dexamethasone-induced FKBP5 gene expression incubated for 24 hrs by RT-qPCR method ChEMBL_474430 Antagonist activity at human GR ligand binding domain expressed in african green monkey COS7 cells in presence of Dexamethasone by Gal4 hybrid assay ChEMBL_839889 Displacement of [3H]dexamethasone from human glucocorticoid receptor expressed in baculovirus infected Sf9 cells after 16-18 hrs by beta counting ChEBML_1685152 Antagonist activity at human GRalpha expressed in HEK293 cells assessed as inhibition of dexamethasone-induced response after 24 hrs by luciferase reporter gene assay ChEMBL_1736310 Antagonist activity at GR in mini pig PBMC assessed as reduction in dexamethasone-induced GILZ gene expression incubated for 24 hrs by RT-qPCR method ChEMBL_1736311 Antagonist activity at GR in mini pig PBMC assessed as reduction in dexamethasone-induced FKBP5 gene expression incubated for 24 hrs by RT-qPCR method ChEMBL_702551 Modulation of glucocorticoid receptor in human SKGT4 cells assessed as receptor translocation from cytoplasm to nucleus after 4 hrs by Hoechst staining relative to Dexamethasone ChEBML_78556 Inhibition of the incorporation of sodium [14C]acetate into cholesterol in HEP G2 cells. ChEMBL_78556 Inhibition of the incorporation of sodium [14C]acetate into cholesterol in HEP G2 cells. ChEMBL_1467008 Inhibition of FASN in human PANC1 cells assessed as inhibition of [14C]acetate incorporation preincubated for 4 hrs before [14C]acetate addition measured after 2 hrs by scintillation counting ChEMBL_1467009 Inhibition of FASN in human BxPC3 cells assessed as inhibition of [14C]acetate incorporation preincubated for 4 hrs before [14C]acetate addition measured after 2 hrs by scintillation counting ChEMBL_1736254 Antagonist activity at human GR expressed in CHO-K1 cells assessed as reduction in dexamethasone-induced response incubated for 20 hrs by luciferase reporter gene assay ChEMBL_802422 Antagonist activity at glucocorticoid receptor in human A549 cells assessed as inhibition of dexamethasone-induced transcription at GRE after 24 hrs by luciferase reporter gene assay ChEMBL_839891 Antagonist activity at glucocorticoid receptor in rat H4IIE cells assessed as inhibition of dexamethasone-induced trypsine aminotransferase expression after 24 hrs by reporter gene assay ChEMBL_873649 Displacement of TAMRA-labeled Dexamethasone from human mineralocorticoid receptor expressed in baculovirus infected insect cell lysate after 60 mins by fluorescence polarization assay ChEMBL_886648 Antagonist activity at glucocorticoid receptor in human SW1353 cells assessed as inhibition of dexamethasone-induced luciferase expression after 16 hrs by MMTV5 reporter gene assay ChEMBL_1677382 Inhibition of ACC1 in human HCT116 cells assessed as reduction of [14C]acetate uptake preincubated for 60 mins followed by addition of [14C]acetate and measured after 2 hrs by scintillation counting analysis ChEMBL_1658415 Displacement of TAMRA-labeled dexamethasone from full-length human mineralocorticoid receptor expressed in baculovirus infected insect cells after 60 mins by fluorescence polarization assay ChEMBL_1735696 Antagonist activity at human CMX-GRalpha expressed in HEK293 cells assessed as reduction in dexamethasone-induced transactivation activity after 24 hrs by luciferase reporter gene assay ChEMBL_839720 Antagonist activity at human glucocorticoid receptor expressed in GRAF cells assessed as inhibition of dexamethasone-induced alkaline phosphatase expression after 48 hrs by reporter gene assay ChEMBL_839890 Antagonist activity at human glucocorticoid receptor expressed in CHOK1 cells assessed as inhibition of dexamethasone-induced alkaline phosphatase expression after 46 hrs by reporter gene assay ChEMBL_1762692 Inhibition of human liver carboxylesterase 1 using o-nitrophenyl acetate as substrate ChEMBL_1778534 Inhibition of human liver carboxylesterase 1 using o-nitrophenyl acetate as substrate ChEMBL_2032946 Inhibition of human erythrocyte CA1 using 4-nitrophenyl acetate as substrate by spectrophotometry ChEMBL_2032947 Inhibition of human erythrocyte CA2 using 4-nitrophenyl acetate as substrate by spectrophotometry ChEMBL_463122 Inhibition of human carbonic anhydrase 1 assessed as 4-nitrophenyl acetate hydrolysis ChEMBL_463123 Inhibition of human carbonic anhydrase 2 assessed as 4-nitrophenyl acetate hydrolysis ChEMBL_463124 Inhibition of mouse carbonic anhydrase 13 assessed as 4-nitrophenyl acetate hydrolysis ChEMBL_520160 Inhibition of human liver CE1-mediated O-nitrophenyl acetate hydrolysis by spectrophotometry ChEMBL_697897 Inhibition of human intestinal CE1 using O-nitrophenyl acetate as substrate by spectrophotometry ChEMBL_1295697 Competitive binding affinity to mineralocorticoid receptor (unknown origin) expressed in baculovirus-infected cell system after 1 hr by fluorescence polarization assay in presence of tetramethylrhodamine-labeled dexamethasone ChEMBL_1295699 Competitive binding affinity to glucocorticoid receptor (unknown origin) expressed in baculovirus-infected cell system after 1 hr by fluorescence polarization assay in presence of tetramethylrhodamine-labeled dexamethasone ChEMBL_1499886 Antagonist activity at human glucocorticoid receptor transfected in CHOK1 cells assessed as inhibition of dexamethasone-induced receptor transcriptional activity after 6 hrs by luciferase reporter gene assay ChEMBL_634775 Antagonist activity at GR in human A549 cells transfected with luciferase gene linked to MMTV promoter assessed as inhibition of dexamethasone-induced luciferase transactivation activity after 24 hrs ChEMBL_728109 Agonist activity at GR expressed in african green monkey CV1 cells transfected with luciferase gene linked to MMTV promoter assessed as induction of luciferase transactivation activity relative to Dexamethasone ChEMBL_1840943 Inhibition of ACC1 in human HCT116 cells assessed as reduction in [14C]acetate uptake preincubated for 60 mins followed by [14C]acetate addition and measured after 2 hrs by top count scintillation counting method ChEMBL_1908133 Inhibition of ACC1 in human HCT116 cells assessed as reduction in [14C]acetate uptake preincubated for 60 mins followed by [14C]acetate addition and measured after 2 hrs by top count scintillation counting method ChEBML_1697025 Inhibition of pig liver carboxylesterase using 4-nitrophenol acetate as substrate by spectrophotometric analysis ChEMBL_1549819 Inhibition of porcine liver carboxylesterase using 4-nitrophenol acetate as substrate by spectrophotometric analysis ChEMBL_2054747 Inhibition of human carbonic anhydrase 2 using 4-nitrophenyl acetate as substrate by spectrophotometry ChEMBL_564154 Inhibition of human erythrocyte CA1 esterase activity using 4-nitrophenyl acetate substrate ChEMBL_564155 Inhibition of human erythrocyte CA2 esterase activity using 4-nitrophenyl acetate substrate ChEMBL_791004 Inhibition of pig liver carboxylesterase using p-nitrophenyl acetate as substrate by spectrophotometric analysis ChEMBL_1759556 Antagonist activity at glucocorticoid receptor (unknown origin) expressed in human ChaGoK1 cells assessed as inhibition of dexamethasone induced transactivation incubated for 24 hrs by beta-galactosidase reporter gene assay ChEMBL_1904911 Antagonist activity at human glucocorticoid receptor expressed in CHO-K1 cells assessed as inhibition of glucocorticoid receptor-dexamethasone coactivator protein-protein interaction incubated for 24 hrs by bioluminescence assay ChEMBL_1551183 Inhibition of human carbonic anhydrase-1 using p-nitrophenyl acetate as substrate by esterase assay ChEMBL_1551184 Inhibition of human carbonic anhydrase-2 using p-nitrophenyl acetate as substrate by esterase assay ChEMBL_591600 Inhibition of para-aminophenylmercuric acetate-activated human pro-MMP8 after 4 hrs by fluorimetry ChEMBL_591603 Inhibition of para-aminophenylmercuric acetate-activated human pro-MMP1 after 4 hrs by fluorimetry ChEMBL_591604 Inhibition of para-aminophenylmercuric acetate-activated human pro-MMP13 after 4 hrs by fluorimetry ChEMBL_628071 Inhibition of human HDAC1 assessed as [3H]acetate release after 90 mins by scintillation counting ChEMBL_631316 Inhibition of dexamethasone-induced human NR1-1a/NR2A receptor-mediated excitotoxicity in (S)-glutamate/glycine-stimulated mouse L12-G10 cells assessed as LDH release after 30 mins ChEMBL_631318 Inhibition of dexamethasone-induced human NR1-1a/NR2B receptor-mediated excitotoxicity in (S)-glutamate/glycine-stimulated mouse L13-E6 cells assessed as LDH release after 30 mins ChEMBL_728111 Agonist activity at GR expressed in IL-1beta- and TNFalpha-stimulated HepG2 cells assessed as inhibition of NFKB- or AP-1 mediated E-selectin transcription by luciferase reporter gene assay relative to Dexamethasone ChEMBL_1452411 Inhibition of bovine erythrocyte carbonic anhydrase 2 using 4-nitrophenyl acetate substrate by photometric assay ChEMBL_1671094 Inhibition of human AChE using p-nitrophenyl acetate as substrate measured for 30 secs by spectrophotometric analysis ChEMBL_2032949 Inhibition of human erythrocyte CA2 using 4-nitrophenyl acetate as substrate by Lineweaver-Burk plot analysis ChEMBL_762141 Inhibition of human liver carboxylesterase1 using o-nitrophenyl acetate as substrate after 5 mins by spectrophotometry ChEMBL_762142 Inhibition of human intestinal carboxylesterase using o-nitrophenyl acetate as substrate after 5 mins by spectrophotometry ChEMBL_762143 Inhibition of rabbit liver carboxylesterase using o-nitrophenyl acetate as substrate after for 5 mins by spectrophotometry ChEMBL_1986667 Inhibition of human carbonic anhydrase 2 using p-nitrophenyl acetate as substrate by UV-VIS spectrophotometric analysis ChEMBL_1986668 Inhibition of human carbonic anhydrase 9 using p-nitrophenyl acetate as substrate by UV-VIS spectrophotometric analysis ChEMBL_1986669 Inhibition of human carbonic anhydrase 5A using p-nitrophenyl acetate as substrate by UV-VIS spectrophotometric analysis ChEMBL_2032948 Inhibition of human erythrocyte CA1 b using 4-nitrophenyl acetate as substrate by Lineweaver-Burk plot analysis ChEMBL_2107117 Inhibition of human carbonic anhydrase 2 using p-nitrophenyl acetate as substrate by UV-VIS spectrophotometric analysis ChEMBL_2107118 Inhibition of human carbonic anhydrase 9 using p-nitrophenyl acetate as substrate by UV-VIS spectrophotometric analysis ChEMBL_771324 Inhibition of FAS in mouse N42 cells assessed as [14C]-acetate incorporation after 4 hrs by scintillation counting Spectroscopic Assay Formation of the hydroxylated product and depletion of NADPH were measured following ethyl acetate extraction of the reaction mixture. ChEMBL_1497288 Antagonist activity at human glucocorticoid receptor expressed in CHOK1 cells assessed as inhibition of dexamethasone-induced protein interaction with steroid receptor co-activator peptide after overnight incubation by beta-galactosidase reporter gene assay GR Binding Assay and GRAF Assay For compounds able to displace the 3(H)-dexamethasone from the receptor an IC50 value (the concentration required to inhibit 50% of the binding of 3(H)-dex) was determined by a nonlinear four parameter logistic model. The EC50s are the concentrations of compounds required to inhibit 50% of dexamethasone-induced alkaline phosphatase (ALP) expression in GRAF cell line, which is produced by CHO-K1 cells stably transfected with GR and a reporter construct containing a glucocorticoid response element driving expression of ALP. GR Binding Assay and Human IL-6 Assay The IC50s were determined by incubating the receptors with radiolabeled dexamethasone in the presence of full log scale concentrations (10-11 M to 10-6 M) of cold dexamethasone or the ligands. The IC50s were calculated assuming a single binding site sigmoidal dose-response model. The EC50s were obtained from transcriptional repression of IL-6-release using the human A549 lung epithelial cell line and freshly isolated mouse thioglycolate-elicited peritoneal exudate cells. ChEMBL_1658413 Antagonist activity at GAL4-fused human GR LBD (443 to 777 residues) expressed in CHO-K1 cells assessed as inhibition of dexamethasone-induced transactivation activity after 5 to 6 hrs by luciferase reporter gene assay ChEMBL_1464326 Inhibition of bovine carbonic anhydrase 2 assessed as hydrolysis of p-nitrophenyl acetate after 30 mins by spectrophotometric method ChEMBL_1881816 Inhibition of human carbonic anhydrase 2 using 4-nitrophenyl acetate as substrate after 20 mins by spectrophotometric analysis ChEMBL_2102188 Inhibition of human ABHD6 expressed in Expi293 cells using p-nitrophenyl acetate as substrate incubated for 30 mins by spectrophotometry ChEMBL_591599 Inhibition of para-aminophenylmercuric acetate-activated human recombinant pro-MMP9 catalytic domain after 4 hrs by fluorimetry ChEMBL_591602 Inhibition of para-aminophenylmercuric acetate-activated human recombinant pro-MMP2 catalytic domain after 4 hrs by fluorimetry ChEMBL_615079 Inhibition of human carbonic anhydrase 2 assessed as conversion of 4-nitrophenyl acetate to 4-nitrophnolate after 5 mins ChEMBL_80669 In vitro inhibitory activity was measured against rat liver HMG-CoA reductase using [2-14C]-acetate incorporation Esterase Activity Assay Kinetic studies were performed using the esterase activity method, with 4-nitrophenyl acetate (NPA) as substrate. Receptor Binding Assay Binding Assay (I):In order to assess the affinity of test compounds for the human glucocorticoid receptor, a commercially available kit was used (Glucocorticoid Receptor Competitor Assay Kit, Invitrogen Part #2893). Briefly, purified human recombinant full-length glucocorticoid receptor (2 nM) was mixed with fluorescently labeled glucocorticoid (1 nM Fluormone GS Red) in the presence or absence of test compound. After two hour incubation at room temperature in the dark, the fluorescence polarization (FP) of the samples was measured. The FP of a mixture of receptor, fluorescent probe (i.e., Fluormone GS Red) and 5 μM dexamethasone represented background fluorescence or 100% inhibition, whereas, the FP of the mixture without dexamethasone (but in the presence of vehicle) was taken to be 100% binding. The percentage inhibition of test compounds were then compared to the sample with 5 μM dexamethasone and expressed as % relative binding activity with dexamethasone being 100% and no inhibition is 0%. Test compounds were analyzed in the concentration range from 8.5E-05 μM to 5 μM. Binding Assay (II):In order to measure the binding of compounds on the glucocorticoid receptor a commercially available kit was used (Glucocorticoid receptor competitor assay kit, PanVera Co., Madison, Wis., P2816). Briefly, a cell lysate containing recombinantly expressed human full-length glucocorticoid receptor was mixed with a fluorescently labeled glucocorticoid (1 nM Fluormone GS1) in the presence or absence of test compound. After one hour at room temperature, the fluorescence polarization (FP) of the samples were measured. The FP of a mixture of receptor, fluorescent probe (i.e., Fluormone GS1) and 1 mM dexamethasone represented background fluorescence or 100% inhibition, whereas, the FP of the mixture without dexamethasone was taken to be 100% binding. The percentage inhibition of test molecules were then compared to the sample with 1 mM dexamethasone and expressed as % relative binding activity with dexamethasone being 100% and no inhibition is 0%. Test molecules were analyzed in the concentration range from 2.4 nM to 40 μM.Site I binding assays for any NHR (Nuclear Hormone Receptor) are conducted similarly to the above. An appropriate cell lysate or purified NHR is used as the source of the NHR. The fluorescent probe and unlabeled competitor are appropriate for the specific NHR, i.e., are ligands for the specific NHR. ChEMBL_1278120 Inhibition of human kallikrein using H-Pro-Phe-Arg-AMC acetate salt as substrate measured for 30 mins by spectrophotometry ChEMBL_1440135 Antagonist activity against human FFA2 receptor expressed in HEK293 cells assessed as inhibition of sodium acetate-induced calcium mobilization ChEMBL_1812048 Inhibition of Aurora A (unknown origin) using kemptide acetate salt as substrate after 30 mins by kinase-Glo luminescence method ChEMBL_2122327 Inhibition of ACSS2 in human HCT-15 cells assessed as inhibition of 14C acetate incorporation into histones by microbeta scintillation counting analysis Binding Assay In order to measure the binding of compounds on the glucocorticoid receptor a commercially available kit was used (Glucocorticoid receptor competitor assay kit, PanVera Co., Madison, Wis., P2816). Briefly, a cell lysate containing recombinantly expressed human full-length glucocorticoid receptor was mixed with a fluorescently labeled glucocorticoid (1 nM Fluormone GS1) in the presence or absence of test compound. After one hour at room temperature, the fluorescence polarization (FP) of the samples were measured. The FP of a mixture of receptor, fluorescent probe (i.e., Fluormone GS1) and 1 mM dexamethasone represented background fluorescence or 100% inhibition, whereas, the FP of the mixture without dexamethasone was taken to be 100% binding. The percentage inhibition of test molecules were then compared to the sample with 1 mM dexamethasone and expressed as % relative binding activity with dexamethasone being 100% and no inhibition is 0%. Test molecules were analyzed in the concentration range from 2.4 nM to 40 μM.Site I binding assays for any NHR (Nuclear Hormone Receptor) are conducted similarly to the above. An appropriate cell lysate or purified NHR is used as the source of the NHR. The fluorescent probe and unlabeled competitor are appropriate for the specific NHR, i.e., are ligands for the specific NHR. ChEBML_80478 Inhibition of cellular HMG-CoA reductase in cultures of human HEP G2 cells, determined by decreased incorporation of sodium [14C]acetate into cholesterol. ChEMBL_1524266 Inhibition of human thrombin using tosyl-glycyl-prolyl-arginine-4-nitranilide acetate as substrate preincubated for 10 mins by spectrophotometer analysis ChEMBL_1704270 Inhibition of porcine liver carboxylesterase using 4-nitrophenol acetate as substrate preincubated for 10 mins followed by substrate addition by spectrophotometric analysis ChEMBL_1778962 Inhibition of porcine liver carboxylesterase using 4-nitrophenol acetate as substrate incubated for 10 mins followed by substrate addition by spectrophotometric method ChEMBL_1812049 Inhibition of Aurora B (unknown origin) using kemptide acetate salt as substrate after 30 mins by kinase-Glo luminescence method ChEMBL_2122326 Inhibition of ACSS2 in human HCT-15 cells assessed as inhibition of 14C acetate incorporation into fatty acids by microbeta scintillation counting analysis ChEMBL_487696 Inhibition of human recombinant carbonic anhydrase 2 assessed as activity of carbonic anhydrase 2 esterase activity against 4-nitrophenyl acetate GR-Mediated Antagonist Activity Assay and IL-6 Repression Assay GR-Mediated Antagonist Activity Assay- GR-mediated antagonist activity is measured in the presence of a concentration of dexamethasone empirically determined to give half-maximal response. The antagonist activity of compounds, their activity in inhibiting dexamethasone response to basal level, is reported as % absolute efficacy. Potencies of compounds are reported as the concentration at which they reach half their antagonist (IC50) activity. IL-6 Repression Assay- The GR-mediated repression of IL-6 production in a human fibroblast (NHDFneo) cell line is measured with a modified ELISA assay. ChEMBL_1440170 Antagonist activity against FFA2 receptor in human whole blood assessed as inhibition of sodium acetate-induced CD11b[AE] expression by flow cytometry ChEMBL_1757787 Competitive inhibition of electric eel AChE assessed as enzyme-inhibitor complex using p-nitrophenyl acetate as substrate by Lineweaver-Burk plot analysis ChEMBL_1739641 Inhibition of human carbonic anhydrase 9 expressed in Escherichia coli BL21 D3 strain using p-nitrophenyl acetate as substrate by UV/visible spectrophotometry ChEMBL_1739642 Inhibition of human carbonic anhydrase 2 expressed in Escherichia coli BL21 D3 strain using p-nitrophenyl acetate as substrate by UV/visible spectrophotometry ChEMBL_1757782 Mixed-type inhibition of electric eel AChE assessed as enzyme-inhibitor complex using p-nitrophenyl acetate as substrate by Lineweaver-Burk plot analysis ChEMBL_1757784 Uncompetitive inhibition of electric eel AChE assessed as enzyme-substrate-inhibitor complex using p-nitrophenyl acetate as substrate by Lineweaver-Burk plot analysis ChEMBL_1757785 Non-competitive inhibition of electric eel AChE assessed as enzyme-inhibitor complex using p-nitrophenyl acetate as substrate by Lineweaver-Burk plot analysis ChEMBL_1772793 Inhibition of human thrombin using tosyl-glycyl-prolyl-arginine-4-nitranilide acetate as substrate preincubated for 10 mins followed by substrate addition by spectrophotometer ChEMBL_1899908 Inhibition of FASN in human BT474 cells preincubated for 1 hr followed by [14C]-acetate addition and measured after 4 hrs by scintillation counting assay ChEMBL_811227 Inhibition of human recombinant his-tagged MAGL expressed in Escherichia coli assessed as hydrolysis of 4-nitrophenyl acetate after 20 mins by microplate reader ChEBML_1649819 Inhibition of human intestinal CES2 expressed in baculovirus infected sf9 cells using o-nitrophenyl acetate as substrate monitored at 15 secs interval for 5 mins ChEMBL_1649818 Inhibition of human liver CES1 expressed in baculovirus infected sf9 cells using o-nitrophenyl acetate as substrate monitored at 15 secs interval for 5 mins ChEMBL_1649819 Inhibition of human intestinal CES2 expressed in baculovirus infected sf9 cells using o-nitrophenyl acetate as substrate monitored at 15 secs interval for 5 mins ChEMBL_1757783 Mixed-type inhibition of electric eel AChE assessed as enzyme-substrate-inhibitor complex using p-nitrophenyl acetate as substrate by Lineweaver-Burk plot analysis ChEMBL_1757786 Non-competitive inhibition of electric eel AChE assessed as enzyme-substrate-inhibitor complex using p-nitrophenyl acetate as substrate by Lineweaver-Burk plot analysis ChEMBL_1761089 Inhibition of human thrombin using tosyl-glycyl-prolyl-arginine-4-nitranilide acetate as substrate preincubated for 10 mins followed by substrate addition by spectrophotometric method ChEMBL_1867284 Inhibition of ACSS2 in human MDA-MB-468 cells assessed as 13C-acetate incorporation incubated for 5 hrs measured under hypoxic conditions by LCMS analysis
BDBM323654 US10188667, Dexamethasone
1-(2-bromo-4-chloro-phenyl)sulfonylpiperidine 1-[(2-bromo-4-chlorophenyl)sulfonyl]piperidine MLS000028544 BDBM44576 DEXAMETHASONE 21-ACETATE MLS000060983 SMR000058327 1-(2-bromo-4-chlorophenyl)sulfonylpiperidine DEXAMETHASONE ACETATE cid_772156 SMR000069748 cid_236702 1-(2-bromanyl-4-chloranyl-phenyl)sulfonylpiperidine
BDBM235670 Dexamethasone sodium phosphate
dexamethasone (tetramethyl-rhodamine conjugated ) BDBM18703
o-NPA BDBM22723 o-nitrophenyl acetate Nitrophenyl Acetate 2-nitrophenyl acetate
BDBM11326 4-nitrophenyl acetate p-Nitrophenyl Acetate
dexamethasone (1R,2S,10S,11S,13R,14R,15S,17S)-1-fluoro-14,17-dihydroxy-14-(2-hydroxyacetyl)-2,13,15-trimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-3,6-dien-5-one BDBM18207 dexamethasone (tetramethyl-rhodamine conjugated ) US10869929, Compound Dexamethasone
acetic acid, sodium salt sodium acetate CHEMBL1354 BDBM50159793 Natriumazetat anhydrous sodium acetate SODIUM ACETATE ANHYDROUS
BDBM233194 Methylprednisolone acetate
BDBM50442911 RETINYL ACETATE
NERYL ACETATE BDBM50036947
ROXATIDINE ACETATE BDBM50404032
beta-amyrinacetate CHEMBL489760 BDBM50260203 Germanicol 3-acetate beta-amyrin acetate
2-[4-(heptyloxy)phenyl]acetate [4-(heptyloxy)phenyl]acetate, 9 BDBM23440
Glutinol acetate CHEMBL487567 BDBM50275350 glutin-5-en-3-beta-O-acetate
BDBM50430740 CHEMBL2333940 Cedryl Acetate
BDBM50439263 1-NITROSOCYCLOHEXYL ACETATE
Midecamycin BDBM50248300 Midecamycin Acetate
ULIPRISTAL ACETATE BDBM50375424 Ulipristal
(+/-)-threo-Ritalinol acetate BDBM50327104 CHEMBL1253489
ABIRATERONE ACETATE BDBM50407398 CB7630 Zytiga
BDBM50137051 [(2-ammoniopropanoyl)amino]acetate
BDBM50340426 16-Dehydropregnenolone acetate CHEMBL1761683
CHEBI:70478 BDBM50037054 CITRONELLYL ACETATE
CHEMBL1085948 ethyl bromo acetate BDBM50318514
CHEMBL1221460 Epihippuristanol 3-Acetate BDBM50482554
CHEMBL1222308 BDBM50482560 Hippuristanol 3-Acetate
Calyculin A 21-acetate (13) BDBM40780
Cortone Cortisone acetate BDBM50455157 Cortisone
GERANYL ACETATE BDBM50037025 CHEBI:5331
lupeol 3-acetate BDBM50317548 CHEMBL1097034
BDBM50248241 Cetrorelix Acetate D-20761 CHEBI:31387 Cetrotide NS-75A SB-075 Acetate Cetrorelix
2-(4-aminobenzamido)acetate BDBM50270006 AMINOHIPPURATE
2Alpha,10Beta-Dihydroxycedryl Acetate BDBM50430738 CHEMBL2333939
CHEBI:27750 BDBM50128823 Ethyl acetate E1504
[(3-ammoniopropanoyl)amino]acetate BDBM50137022 CHEMBL157332
6-chloro-3,20-dioxo-1beta,2beta-dihydro-3'H-cyclopropa[1,2]pregna-4,6-dien-17-yl acetate cyproterone acetate cid_9880 CHEMBL139835 Cyproterone 17-O-acetate BDBM50094569
3-cyanoquinuclidin-3-yl acetate CHEMBL1652416 BDBM50335539
BDBM50103520 GLYCINEBETAINE CHEBI:17750 2-(Trimethylammonio)Acetate
BDBM50136974 CHEMBL346341 {methyl[(methylammonio)acetyl]amino}acetate
BDBM50252742 CHEMBL493460 Isosorbide-2-benzylcarbamate-5-acetate
BDBM50321267 CHEMBL1163190 methyl 2-(o-tolyloxy)acetate
BDBM50321268 methyl 2-(2-ethylphenoxy)acetate CHEMBL1163834
BDBM50321269 methyl 2-(4-ethylphenoxy)acetate CHEMBL1163835
BDBM50321271 ethyl 2-(3-ethylphenoxy)acetate CHEMBL1163911
CHEMBL154491 BDBM50137001 [(pyrrolidinium-2-ylcarbonyl)amino]acetate
CHEMBL279115 phorbol 13-acetate 12-myristate BDBM50099066
Finaplix RU-1697 Trenbolone Acetate BDBM50190646 Trenbolone
Methyl 2-(Tert-Butoxycarbonylsulfamoylamino)Acetate BDBM50428799 CHEMBL450699
Zoladex BDBM50247974 Goserelin Acetate Novgos Zoladex LA
[(2-ammoniopropanoyl)(methyl)amino]acetate BDBM50137029 CHEMBL348602
ethyl 2-(m-tolyloxy)acetate BDBM50321270 CHEMBL1163910
Methylacetoxyprogesterone US9271961, MPA MEDROXYPROGESTERONE 6-alpha-Methyl-17-alpha-hydroxyprogesterone acetate Medroxyprogesterone 17-acetate (6alpha)-6-methyl-3,20-dioxopregn-4-en-17-yl acetate Medroxyacetate progesterone 6alpha-Methyl-17alpha-hydroxyprogesterone acetate medroxyprogesterone acetate 17-Acetoxy-6alpha-methylprogesterone 17alpha-Hydroxy-6alpha-methylprogesterone acetate 6-alpha-Methyl-17-alpha-acetoxyprogesterone 6alpha-Methyl-17-acetoxy progesterone Metigestrona BDBM50067678 (6alpha)-17-(Acetyloxy)-6-methylpreg-4-ene-3,20-dione 6alpha-Methyl-4-pregnene-3,20-dion-17alpha-ol acetate
METHYLPHENIDATE methyl (S)-phenyl[(S)-piperidin-2-yl]acetate methyl (2S)-phenyl[(2S)-piperidin-2-yl]acetate BDBM50062909
Concentraid DDAVP Noqdirna Ddavp (Needs No Refrigeration) Presinex Minirin Octim BDBM50247923 Stimate (Needs No Refrigeration) Desmopressin Acetate Desmotabs Desmomelt Desmopressin acetate preservative free Desmospray Noctiva Desmopressin Acetate (Needs No Refrigeration) Nocutil Octostim Stimate
CHEMBL827 methyl (2R)-phenyl[(2R)-piperidin-2-yl]acetate METHYLPHENIDATE BDBM50062915 methyl (R)-phenyl[(R)-piperidin-2-yl]acetate
BDBM50072589 CHEMBL110361 Sodium; difluoro-naphthalen-2-yl-acetate
BDBM50287711 [methyl({[(phosphonatooxy)phosphinato]oxy}acetyl)amino]acetate
CHEMBL114030 Sodium; biphenyl-3-yl-difluoro-acetate BDBM50072594
CHEMBL154651 BDBM50136980 [(2-ammonio-3-mercaptopropanoyl)amino]acetate
Substrate analogue, 16 [(ammonioacetyl)amino]acetate glycylglycine BDBM50137044
[(2-{[(phosphonatooxy)phosphinato]oxy}ethyl)thio]acetate BDBM50287712
3,20-Dioxopregn-4-ene-17-yl acetate (4) BDBM235654
BDBM50136976 CHEMBL152259 [(2-ammonio-3-phenylpropanoyl)(methyl)amino]acetate
BDBM50283572 Sodium; (3-carboxy-5-phosphonomethyl-phenoxy)-acetate CHEMBL262641
BDBM50283577 Sodium; (3-carboxy-5-phosphono-phenoxy)-acetate CHEMBL88094
CHEMBL1163917 ethyl 2-(4-allyl-2-methoxyphenoxy)acetate BDBM50321263
CHEMBL232590 methyl 2-(2-(4-formylphenoxy)acetamido)acetate BDBM50206195
CHEMBL247131 methyl 2-(4-chloro-2-cyclohexylphenoxy)acetate BDBM50213924
CHEMBL397101 BDBM50219225 4-(10H-phenothiazine-10-carbonyl)phenyl acetate
[methyl(2-{[(phosphonatooxy)phosphinato]oxy}ethyl)amino]acetate BDBM50287713
ethyl 2-(2-(3-phenylpropanoyl)phenoxy)acetate CHEMBL223539 BDBM50207952
methyl 2-(4-ethyl-2-nitrophenoxy)acetate CHEMBL1163201 BDBM50321272
methyl 2-(3,4-dichlorophenyl)-2-(piperidin-2-yl)acetate (RS/SR)-methyl 2-(3,4-dichlorophenyl)-2-(piperidin-2-yl)acetate CHEMBL220195 BDBM50202391
(S)-mandelic acid (2S)-hydroxy(phenyl)acetate (S)-mandelate BDBM50129063
1-(4-Cyanobenzyl)-5-(methylene-acetate)-1H-imidazole CHEMBL599222 BDBM50307236
BDBM233041 3,20-Dioxopregna-4,6-dien-17α-yl acetate (7)
BDBM237307 4-Acetamidophenyl 2-(2-(4-isobutylphenyl)propanamido)acetate (8)
BDBM23800 Triphenylmethyl-containing compound, 29 methyl 2-[(triphenylmethyl)sulfanyl]acetate
BDBM50075080 Sodium; [2-(cyclohexanesulfonylamino-methyl)-indan-5-yl]-acetate CHEMBL130460
BDBM50279380 CHEMBL453955 methyl 2-((1R,2S)-2-(benzyloxycarbonylamino)cyclobutanecarboxamido)acetate
CHEMBL1095503 3,3-Dimethylbutyl 2-(2-(2,6-Dichlorophenylamino)phenyl)acetate BDBM50316991
CHEMBL595729 2-(4,5-dichlorothiophen-3-yl)-2-oxoethyl acetate BDBM50304461
Sodium; [2-(benzenesulfonylamino-methyl)-indan-5-yl]-acetate BDBM50075086 CHEMBL341221
Sodium; [2-(phenylmethanesulfonylamino-methyl)-indan-5-yl]-acetate CHEMBL132573 BDBM50075078
(RS/SR)-methyl 2-(4-chlorophenyl)-2-(piperidin-2-yl)acetate (RR/SS)-methyl 2-(4-chlorophenyl)-2-(piperidin-2-yl)acetate BDBM50202383 CHEMBL219116
BDBM239153 Ethyl 2-(4-(naphthalen-1-ylamino)-4-oxobutanamido)acetate (5b)
BDBM50215663 4-methoxybenzyl 2-(N-(2-ethylphenyl)-4-methylphenylsulfonamido)acetate CHEMBL234600
BDBM50232253 methyl 2-(5-(benzylthio)-1,3,4-thiadiazol-2-ylthio)acetate CHEMBL252526
BDBM50272298 CHEMBL500419 (-)-N-cyclobutylmethylmorphinan-3-yl-14-ol phenoxy acetate hydrochloride
BDBM50303360 ethyl 2-(3,3-Diethyl-2,4-dioxoazetidin-1-yl)acetate CHEMBL271820
BDBM50306746 CHEMBL599548 3-(5-amino-4-carbamoyloxazol-2-yl)phenyl acetate
CHEMBL1095189 2-(Trimethylsilyl)ethyl 2-(2-(2,6-Dichlorophenylamino)phenyl)acetate BDBM50316990
CHEMBL1163189 Methyl 2-(5-hydroxy-2-methoxy-4-propylphenoxy)acetate BDBM50321274
CHEMBL1164144 BDBM50321273 Methyl 2-(5-amino-2-methoxy-4-propylphenoxy)acetate
CHEMBL133420 Sodium; [2-(4-chloro-benzenesulfonylamino)-indan-5-yl]-acetate BDBM50075089
CHEMBL213132 BDBM50189971 methyl 2-(4-(3-(2-propylphenoxy)propoxy)phenoxy)acetate
CHEMBL494130 4-(4-(6-chloroquinazolin-4-ylamino)butoxy)phenyl acetate BDBM50257748
ethyl 2-oxo-2-(4-styrylpyrimidin-2-ylamino)acetate CHEMBL1209746 BDBM50323584
BDBM50250299 (9Z,11S,16R)-dihydroxyoctadeca-9,17-dien-12,14-diyn-1-yl acetate 11(S),16(R)-dihydroxyoctadeca-9Z,17-diene-12,14-diyn-1-yl acetate CHEMBL490698
methyl 2-(3-benzamidophenoxy)ethanoate methyl [3-(benzoylamino)phenoxy]acetate 2-(3-benzamidophenoxy)acetic acid methyl ester SMR000077931 BDBM40879 MLS000064918 methyl 2-(3-benzamidophenoxy)acetate cid_973374
Butyl(2,4-dichlorophenoxy) acetate 2-(2,4-dichlorophenoxy)acetic acid butyl ester butyl 2-(2,4-dichlorophenoxy)acetate BDBM74250 SMR001224484 cid_7206 MLS002152860 butyl 2-[2,4-bis(chloranyl)phenoxy]ethanoate
Sodium; [2-(2,6-dichloro-phenylamino)-phenyl]-acetate ARTHROTEC US11173137, Compound Diclofenac SOLARAZE diclofenac sodium VOLTAREN-XR sodium 2-(2-(2,6-dichlorophenylamino)phenyl)acetate GP 45840 BDBM50174201 VOLTAREN
(E) Ethyl [2-(4-oxo-6-phenylhex)-5-enamido]acetate (3c) BDBM239141
(Z/E)-ethyl 2-((2-oxoindolin-3-ylidene)methylamino)acetate CHEMBL1689594 BDBM50339262
11-methyl-6,11-dihydrothiochromeno[4,3-b]indol-8-yl acetate BDBM50185201 CHEMBL207510
2-(2-Acetoxy-5-(2-chloroethyl)benzyl)-4-ethylphenyl acetate CHEMBL1254859 BDBM50326695
2-(5-(Biphen-4-ylsulfonamido)-1,3,4-thiadiazol-2-yl)acetate CHEMBL1685061 BDBM50338962
3,20-Dioxo-6,7-epoxypregn-4-ene-7α-yl acetate (8) BDBM233042
6-Chloro-3,20-dioxopregna-4,6-diene-17α-yl acetate (9) BDBM233043
Acetic acid 4-allyl-2-methoxy-phenyl ester CHEMBL108299 BDBM50240728 eugenyl acetate
BDBM234419 (S)-Ethyl 2-(2-(2-aminopropanamido)thiazol-4-yl)acetate (4b)
BDBM50009995 2-(1-naphthamido)acetate CHEMBL306898 [(Naphthalene-1-carbonyl)-amino]-acetic acid
BDBM50075083 CHEMBL340073 Sodium; {2-[(pentane-1-sulfonylamino)-methyl]-indan-5-yl}-acetate
BDBM50075090 CHEMBL422441 Sodium; {2-[(naphthalene-1-sulfonylamino)-methyl]-indan-5-yl}-acetate
BDBM50251901 ethyl 2-(2-(2-(phenylsulfonyl)acetamido)thiazol-4-yl)acetate CHEMBL479404
BDBM50269234 CHEMBL526931 12-O-[3-methyl-2-butenoyl]-4-deoxyphorbol 13-acetate
BDBM50478510 CHEBI:70418 3-Acetylaleuritolic Acid Acetyl Aleuritolic Acid Maprounic Acid Acetate
CHEMBL131497 BDBM50075077 Sodium; {2-[(naphthalene-2-sulfonylamino)-methyl]-indan-5-yl}-acetate
CHEMBL134128 Sodium; {2-[(pyridine-3-sulfonylamino)-methyl]-indan-5-yl}-acetate BDBM50075087
CHEMBL1642285 methyl 2-(4-phenyl-1H-1,2,3-triazol-1-yl)acetate BDBM50334624
CHEMBL1779733 4-(5-(2,5-dichlorophenyl)furan-2-carboxamido)-3,5-dimethylbenzyl acetate BDBM50344798
CHEMBL335043 Sodium; {2-[(thiophene-2-sulfonylamino)-methyl]-indan-5-yl}-acetate BDBM50075076
CHEMBL384671 BDBM50209080 methyl 2-(3-(4-hydroxyphenyl)-4,5-dihydroisoxazol-4-yl)acetate
CHEMBL462629 ethyl 2-cyano-2-(quinoxalin-2(1H)-ylidene)acetate BDBM50247466 cid_5600879
CHEMBL493805 (E)-methyl 2-(1-dodecyl-2-oxoindolin-3-ylidene)acetate BDBM50261104
CHEMBL526339 BDBM50272319 Methyl [5-(6-methoxynaphthalen-2-yl)pyridin-3-yl]acetate
CHEMBL564664 BDBM50296433 benzyl 2-(5-(2-fluorophenyl)-1,3,4-oxadiazol-2-ylthio)acetate
Corticotropin Tetracosapeptide COSYNTROPIN Cortrosyn Vicotrope BDBM50017180 CHEBI:3901 Tetracosactide Acetate Tetracosactide Tetracosactrin
Sodium; {2-[(4-chloro-benzenesulfonylamino)-methyl]-indan-5-yl}-acetate BDBM50075088 CHEMBL336846
ethyl 2-(2-(3-(styrylthio)propanamido)thiazol-4-yl)acetate BDBM50191455 CHEMBL213901
CHEMBL132589 FR-181157 Sodium; {3-[(S)-2-(4,5-diphenyl-oxazol-2-yl)-cyclohex-2-enylmethyl]-phenoxy}-acetate Sodium; {3-[2-(4,5-diphenyl-oxazol-2-yl)-cyclohex-2-enylmethyl]-phenoxy}-acetate BDBM50136234 Sodium; {3-[(R)-2-(4,5-diphenyl-oxazol-2-yl)-cyclohex-2-enylmethyl]-phenoxy}-acetate sodium (S)-2-(3-((2-(4,5-diphenyloxazol-2-yl)cyclohex-2-enyl)methyl)phenoxy)acetate
(4-formylphenyl) 2-(4-fluorophenyl)acetate 4-formylphenyl (4-fluorophenyl)acetate (4-methanoylphenyl) 2-(4-fluorophenyl)ethanoate MLS001180493 2-(4-fluorophenyl)acetic acid (4-formylphenyl) ester BDBM63940 cid_820021 SMR000477394
Ethyl 2-(2-((2S,3R)-2-amino-3-methylpentanamido)thiazol- 4-yl)acetate (7b) Ethyl 2-(2-((2S,3R)-2-amino-3-methylpentanamido)thiazol-4-yl)acetate (5b) BDBM234423
Isoquinoline-1,3,4-trione 6k 2-oxo-1-phenyl-2-[(1,3,4-trioxo-1,2,3,4-tetrahydroisoquinolin-5-yl)amino]ethyl acetate BDBM10264 phenyl[(1,3,4-trioxo-1,2,3,4-tetrahydroisoquinolin-5-yl)carbamoyl]methyl acetate
RS-26306 GANIRELIX ACETATE Ac-D-Nal-[D-(pCl)Phe]-D-Pal-Ser-Tyr-D-Har(Et2)-Leu-Har(Et2)-Pro-DAla-NH2 CHEMBL1251 Ganirelix acetate injection BDBM50102454 Ganirelix
sodium 2-(3-((2-(4,5-diphenyloxazol-2-yl)cyclohex-1-enyl)methyl)phenoxy)acetate Sodium; {3-[2-(4,5-diphenyl-oxazol-2-yl)-cyclohex-1-enylmethyl]-phenoxy}-acetate BDBM50136237 CHEMBL132649
(E)-Ethyl 2-(6-(3,4-dimethoxyphenyl)-4-oxohex-5-enamido)acetate (3h) BDBM239146
(R)-methyl 2-(2-fluorophenyl)-2-((R)-piperidin-2-yl)acetate BDBM50327161 CHEMBL1253310
(R)-methyl 2-(3,4-dichlorophenyl)-2-((R)-piperidin-2-yl)acetate BDBM50327157 CHEMBL1179011
(R)-methyl 2-(3,4-dimethoxyphenyl)-2-((R)-piperidin-2-yl)acetate CHEMBL1254516 BDBM50327158
(R)-methyl 2-(3-chlorophenyl)-2-((R)-piperidin-2-yl)acetate CHEMBL1253271 BDBM50327155
(R)-methyl 2-(3-fluorophenyl)-2-((R)-piperidin-2-yl)acetate BDBM50327162 CHEMBL1253311
(R)-methyl 2-(4-aminophenyl)-2-((R)-piperidin-2-yl)acetate CHEMBL1253709 BDBM50327143
(R)-methyl 2-(4-chlorophenyl)-2-((R)-piperidin-2-yl)acetate BDBM50327145 CHEMBL1178924
(R)-methyl 2-(4-fluorophenyl)-2-((R)-piperidin-2-yl)acetate BDBM50327156 CHEMBL1253289
(R)-methyl 2-(4-hydroxyphenyl)-2-((R)-piperidin-2-yl)acetate BDBM50327139 CHEMBL1253698
(R)-methyl 2-(4-nitrophenyl)-2-((R)-piperidin-2-yl)acetate CHEMBL1254439 BDBM50327141
(S)-methyl 2-(3-(4-hydroxyphenyl)-4,5-dihydroisoxazol-5-yl)acetate BDBM50186436 CHEMBL209822
3-hydroxy-17-oxooestra-1,3,5(10)-trien-11a-yl acetate BDBM264476 US9714266, 5
4-Acetamidophenyl 2-(4-(2-(trifluoromethyl)pyridin-4-ylamino)benzamido)acetate CHEMBL605981 BDBM50307799
4-methoxyphenyl 2-(3-(4-hydroxyphenyl)-4,5-dihydroisoxazol-5-yl)acetate CHEMBL211822 BDBM50186433
BDBM50075084 CHEMBL130170 Sodium; {2-[3-(4-chloro-benzenesulfonylamino)-propyl]-indan-5-yl}-acetate
BDBM50075094 CHEMBL132659 Sodium; {2-[2-(4-chloro-benzenesulfonylamino)-ethyl]-indan-5-yl}-acetate
BDBM50085853 Sodium; [2-cyano-5-(pyridin-4-ylmethoxy)-phenoxy]-o-tolyl-acetate CHEMBL173251
BDBM50120471 CHEMBL148054 ethyl 2-[1'-benzylspiro[1,3-dihydroisobenzofuran-1,4'-(hexahydropyridine)]-3-yl]acetate
BDBM50191136 CHEMBL386580 sodium 2-(3-(2-(4,5-diphenyloxazol-2-yl)benzyl)phenoxy)acetate
BDBM50296317 (3R)-1-Azabicyclo[2.2.2]oct-3-ylhydroxy(di-2-thienyl)acetate CHEMBL551729
BDBM50307792 CHEMBL597562 4-Acetamidophenyl 2-(4-(2-(trifluoromethyl)pyridin-4-ylamino)phenyl)acetate
BDBM50327142 (R)-methyl 2-(3-aminophenyl)-2-((R)-piperidin-2-yl)acetate CHEMBL1253708
BDBM50327160 CHEMBL1187951 (R)-methyl 2-(2-chlorophenyl)-2-((R)-piperidin-2-yl)acetate
BDBM50328804 rac-1,2,5-trimethyl-4-(naphthalen-1-ylethynyl)piperidin-4-yl acetate CHEMBL1269951
CHEBI:474180 L-743,872 Caspofungin Acetate Cancidas Caspofungin MK-991 BDBM50478215 L-743872
CHEMBL1087206 BDBM50316980 4-((3,3-Dimethylbutoxy)carbonyloxy)benzyl 2-(2-(2,6-Dichlorophenylamino)phenyl)acetate
CHEMBL1170333 (R)-ethyl 2-(1'-benzylspiro[isochroman-1,4'-piperidine]-3-yl)acetate BDBM50321771
CHEMBL1253270 BDBM50327154 (R)-methyl 2-(3-hydroxyphenyl)-2-((R)-piperidin-2-yl)acetate
CHEMBL1253735 (R)-methyl 2-(4-iodophenyl)-2-((R)-piperidin-2-yl)acetate BDBM50327148
CHEMBL1253736 (R)-methyl 2-(3-bromophenyl)-2-((R)-piperidin-2-yl)acetate BDBM50327149
CHEMBL1269433 BDBM50329092 (Z)-methyl 2-(3-oxo-3,4-dihydroquinoxalin-2(1H)-ylidene)acetate
CHEMBL1783784 ethyl 2-(5-methoxy-2-(3-phenylisoxazol-5-yl)phenoxy)acetate BDBM50346159
CHEMBL225273 3-(6-morpholino-4-oxo-4H-pyran-2-yl)benzyl acetate BDBM50208548
CHEMBL255013 BDBM50235104 methyl 2-(2-(1-phenylcyclopentyl)-4-(quinolin-2-ylmethoxy)phenoxy)acetate
CHEMBL255228 methyl 2-(2-(1-phenylcyclohexyl)-4-(quinolin-2-ylmethoxy)phenoxy)acetate BDBM50235115
CHEMBL496452 BDBM50269198 9alpha,11alpha-epoxycholest-7-ene-3beta,5alpha,6alpha-triol 6-acetate
CHEMBL502799 12-O-[(2R)-N,N-dimethyl-3-methylbutanoyl]phorbol 13-acetate BDBM50269235
Ethyl 2-(3-(3-(difluoromethyl)-1H-pyrazol-5-yl)phenoxy)acetate (3c) BDBM231672
Ethyl 2-(3-(5-(trifluoromethyl)-1H-pyrazol-3-yl)phenoxy)acetate (3b) BDBM231671
Etynodiol Ethynodiol Diacetate Etynodiol diacetate Etynodiol Acetate BDBM50237627 Femulen CHEBI:31580 SC-11800
Megace BDBM50238674 SC-10363 BDH-1298 Megestrol Megestrol Acetate 5071 Ovaban Megace Es
N-Methoxycarbonyl-D-norleucyl-glycyl-L-arginine-4- nitranilide-acetate BDBM31507 Chromozym X
Sodium; {2-[4-(4-chloro-benzenesulfonylamino)-butyl]-indan-5-yl}-acetate BDBM50075095 CHEMBL131336
US9815796, Example 4 BDBM354913 2-Methyl-2-(1H-pyrazol-1-yl)propanimidamide acetate
ethyl 2-(2-(3-(3,4-dichlorophenyl)ureido)thiazol-4-yl)acetate BDBM50336541 CHEMBL1673336
ethyl 2-(4-chloro-2-(3,4,5-trimethoxyphenylamino)pyrimidin-5-yl)acetate BDBM50182011 CHEMBL206796
ethyl 2-(5H-imidazo[5,1-a]isoindol-5-yl)acetate US10233190, Example 1256 BDBM370420
methyl 2-{4-(beta-D-galactopyranosyl)-[1,2,3]triazole-2-ylmethyl}acetate BDBM50272146 CHEMBL502002
Methyl 2,3-Dihydro-2-thioxo-1H-indole-3-acetate 2-thioxo-1H-indole-3-alkanoic acid deriv. 7 BDBM3958 methyl 2-(2-sulfanylidene-2,3-dihydro-1H-indol-3-yl)acetate
(E)-Ethyl 2-(6-(4-(benzyloxy)phenyl)-4-oxohex-5-enamido)acetate (3k) BDBM239149
(R)-methyl 2-(2-chlorophenyl)-2-((R)-piperidin-2-yl)acetate hydrochloride CHEMBL534500 BDBM50212388
(S)-methyl 2-(2,6-dioxo-3-(3,4,5-trimethoxybenzamido)piperidin-1-yl)acetate CHEMBL245917 BDBM50210528
13-methylcarbonyloxy-20-azapentacyclo[7.6.5.02,7.010,15.016,20]icosa-2(7),3,5,12,14-pentaen-4-yl acetate BDBM50122554
4-((2-(Trimethylsilyl)ethoxy)carbonyloxy)benzyl 2-(2-(2,6-Dichlorophenylamino)phenyl)acetate BDBM50316979 CHEMBL1088643
BDBM234418 (S)-Ethyl 2-(2-(2-(tert-butoxycarbonylamino)propanamido)thiazol-4-yl)acetate (4a)
BDBM234427 (S)-Ethyl 2-(2-(2-amino-3-methylbutanamido)thiazol-4-yl)acetate (6b)
BDBM234439 (S)-Ethyl 2-(2-(2-amino-3-phenylpropanamido)thiazol-4-yl)acetate (9b)
BDBM50143930 (3-Cyclohexyl-ureido)-acetic acid methyl ester CHEMBL66518 methyl 2-(3-cyclohexylureido)acetate
BDBM50186427 methyl 2-(3-(3-fluoro-4-hydroxyphenyl)-4,5-dihydroisoxazol-5-yl)acetate CHEMBL212313
BDBM50186429 US8618147, 13 butyl 2-(3-(4-hydroxyphenyl)-4,5-dihydroisoxazol-5-yl)acetate CHEMBL210755
BDBM50189965 CHEMBL211963 methyl 2-(4-(3-(2-propyl-4-(trifluoromethyl)phenoxy)propoxy)phenoxy)acetate
BDBM50248097 2-(4-((2,4-dichlorobenzamido)methyl)-1-(propylsulfonyl)piperidin-4-yl)cyclohexyl acetate CHEMBL462147
BDBM50256074 butyl 2-(4,5-bis(2,4-dichlorophenyl)-2H-1,2,3-triazol-2-yl)acetate CHEMBL481885
BDBM50256540 (S)-N-(2-(4,5-dihydro-1H-imidazol-5-yl)ethyl)acetamide acetate CHEMBL480572
BDBM50273231 ethyl 2-(N-(4-isopropylphenethyl)-2-hydroxy-5-(N'-hydroxycarbamimidoyl)phenylsulfonamido)acetate CHEMBL455919
BDBM50298224 7-oxo-7H-benzimidazo[2,1-a]benz[de]isoquinoline-3-carboxylic acid acetate CHEMBL265470
BDBM50298487 CHEMBL583989 4-(4-(5-oxothiophen-2(5H)-ylidene)hexan-3-yl)phenyl acetate
BDBM50308373 CHEMBL589064 (E)-methyl 2-(5-((2,4-dioxothiazolidin-5-ylidene)methyl)-2-ethoxyphenoxy)acetate
BDBM50327107 CHEMBL1183494 (R)-methyl 2-(naphthalen-2-yl)-2-((R)-piperidin-2-yl)acetate
BDBM50327146 CHEMBL1254440 (R)-methyl 2-(4-tert-butylphenyl)-2-((R)-piperidin-2-yl)acetate
BDBM50327726 CHEMBL1257397 methyl 2-(1-octyl-5-m-tolyl-1H-indol-3-yl)acetate
BDBM50338956 Ethyl 2-(5-(4-Dodecylphenylsulfonamido)-1,3,4-thiadiazol-2-yl)acetate CHEMBL1685055 US9320734, 120E
BDBM533328 (3-{4-[(3-piperidylpropyl)amino]-2- quinolyl}phenyl)methyl acetate US11220486, Compound I258
BR30 BDBM12418 copper(2+) ion 2-[(carboxylatomethyl)({2-[(4-sulfamoylphenyl)formamido]ethyl})amino]acetate
CHEMBL1172971 2-(naphthalen-2-yl)-2-oxoethyl 2-(2-(o-tolyloxy)acetamido)acetate BDBM50322735
CHEMBL1224717 BDBM50325790 methyl 2-(4-((8-(3-methoxyphenyl)quinolin-6-yl)methoxy)phenyl)acetate
CHEMBL1254844 BDBM50327108 (R)-methyl 2-((R)-piperidin-2-yl)-2-(4-(trifluoromethyl)phenyl)acetate
CHEMBL131036 BDBM50075085 Sodium; {2-[(4-chloro-benzenesulfonylamino)-methyl]-2,3-dihydro-benzofuran-5-yl}-acetate
CHEMBL208716 US8618147, 12 BDBM50186425 isopropyl 2-(3-(4-hydroxyphenyl)-4,5-dihydroisoxazol-5-yl)acetate
CHEMBL210194 ethyl 2-(2-(3-nitrobenzamido)-1H-benzo[d]imidazol-1-yl)acetate BDBM50184695
CHEMBL210592 neopentyl 2-(3-(4-hydroxyphenyl)-4,5-dihydroisoxazol-5-yl)acetate US8618147, 16 BDBM50186443
CHEMBL211882 BDBM50186444 neopentyl 2-(3-(3-fluoro-4-hydroxyphenyl)-4,5-dihydroisoxazol-5-yl)acetate
CHEMBL377184 cyclohexylmethyl 2-(3-(4-hydroxyphenyl)-4,5-dihydroisoxazol-5-yl)acetate US8618147, 15 BDBM50186430
CHEMBL378265 BDBM50186435 US8618147, 5 mesityl 2-(3-(4-hydroxyphenyl)-4,5-dihydroisoxazol-5-yl)acetate
CHEMBL378460 3-(4-(4-(4-(hydroxydiphenylmethyl)piperidin-1-yl)butanoyl)phenyl)propyl acetate BDBM50183086
Ethyl 2-(5-(4-Decanamidophenylsulfonamido)-1,3,4-thiadiazol-2-yl)acetate US9320734, 119E CHEMBL1685042 BDBM50338942
N-Methylsulfonyl-D-Phe-Gly-Arg-4-nitranilide acetate Factor VII Chromogenic Substrate BDBM14496
Sodium; (1-benzyl-3-carbamoylmethyl-2-methyl-1H-indol-4-yloxy)-acetate CHEMBL148500 BDBM50055346
US8618147, 10 ethyl 2-(3-(4-hydroxyphenyl)-4,5-dihydroisoxazol-5-yl)acetate BDBM50186442 CHEMBL208658
US8618147, 2 phenyl 2-(3-(4-hydroxyphenyl)-4,5-dihydroisoxazol-5-yl)acetate BDBM50186424 CHEMBL377038
cyclohexyl 2-(3-(4-hydroxyphenyl)-4,5-dihydroisoxazol-5-yl)acetate BDBM50186445 US8618147, 14 CHEMBL209401
ethyl 2-(1-octyl-5-m-tolyl-1H-indol-3-yl)acetate BDBM50327727 CHEMBL1257398
methyl 2-((2S,4S)-4-(3,4,5-trimethoxybenzamido)-1-acetylpyrrolidine-2-carboxamido)acetate BDBM50247523 CHEMBL473732
methyl [1'-(cyclopropylmethyl)-2-oxospiro[indole-3,4'-piperidin]-1(2H)-yl]acetate CHEMBL383561 BDBM50173279
propyl 2-(3-(4-hydroxyphenyl)-4,5-dihydroisoxazol-5-yl)acetate BDBM50186439 US8618147, 11 CHEMBL208659
methyl phenidylacetate BDBM50062912 methyl alpha-phenyl-alpha-(2-piperidyl)acetate alpha-phenyl-2-piperidineacetic acid methyl ester methyl phenyl(piperidin-2-yl)acetate methylphenidan methyl alpha-phenyl-alpha-2-piperidinylacetate CHEMBL796 Methylphenidate
MLS000583399 SMR000185924 BDBM33729 acetic acid (6-methoxy-3-quinolyl) ester (6-methoxyquinolin-3-yl) acetate (6-methoxyquinolin-3-yl) ethanoate acetic acid (6-methoxy-3-quinolinyl) ester cid_867308 6-methoxy-3-quinolinyl acetate
Hemsol-Hc BDBM50474607 Micort-Hc Hydrocortisone 21-acetate Neo-Cortef CHEBI:17609 NSC-741 Gppe Eye Crm Dricort Cortucid Hepacort Plus Orabase Hca Epifoam Genticin HC Barquinol HC Gentisone HC Framycort Hc45 Hydrocort Hydrocortone Gppe Foam Aero Chloromycetin Hydrocort Lanacort Hydrocortisone Acetate Cortifoam Gppe Ear Susp Cortril Fucidin H Cortef Acetate Colifoam Hydrocal
(2-{1-[(4-chlorophenyl)carbonyl]-5-methoxy-2-methylindol-3-yl}acetylamino) acetate CHEMBL429267 BDBM50226647
(3-(4-(3-chlorophenylamino)quinazolin-6-yl)-1-methyltriaz-2-enyl)methyl acetate BDBM50301421 CHEMBL571809
(4-anilinophenyl) acetate cid_2337865 SMR000353326 (4-phenylazanylphenyl) ethanoate MLS001002014 acetic acid (4-anilinophenyl) ester BDBM47972
(R)-ethyl 2-(1'-benzyl-3H-spiro[isobenzofuran-1,4'-piperidine]-3-yl)acetate CHEMBL1172094 BDBM50321760
(S)-Ethyl-2-(3-(2-aminoacetamido)-2,6-dioxopiper idin-1-yl)acetate hydrochloride BDBM50316380 CHEMBL1095916
1-cyclohexyl-2-(5H-imidazo[5,1-a]isoindol-5- yl)ethyl acetate BDBM370501 US10233190, Example 1420
3-Amino-2-hydroxy-N-(3-methyl-butyl)-4-phenyl-thiobutyramide; Trifluoro acetate BDBM50022742 CHEMBL67868
4-Acetamidophenyl 2-(2-(4-(2-(trifluoromethyl)pyridin-4-ylamino)phenyl)acetamido)acetate BDBM50307797 CHEMBL599823
5-oxo-1-tosyl-2,5-dihydro-1Hpyrrol-2-yl acetate BDBM50321258 CHEMBL1164744 CA inhibitor, 17
BDBM233181 Sodium [5-hydroxy-5-(2-methoxy-quinolin-3-yl)-pent-2-ynyloxy]-acetate (18b)
BDBM234426 (S)-Ethyl 2-(2-(2-(tert-butoxycarbonylamino)-3-methylbutanamido)thiazol-4-yl) acetate (6a)
BDBM234430 (S)-Ethyl 2-(2-(2-(tert-butoxycarbonylamino)-4-methylpentanamido)thiazol-4-yl) acetate (7a)
BDBM234435 (S)-Ethyl 2-(2-(2-amino-4-(methylthio)butanamido)thiazol-4-yl)acetate (8b)
BDBM234438 (S)-Ethyl 2-(2-(2-(tert-butoxycarbonylamino)-3-phenylpropanamido)thiazol-4-yl) acetate (9a)
BDBM26745 bisarylimidazole derivative, 4 methyl 2-[3-(4,5-diphenyl-1H-imidazol-1-yl)phenoxy]acetate
BDBM50068691 CHEMBL149152 Lithium; [6-(3,4-dimethyl-isoxazol-5-ylsulfamoyl)-4'-isobutyl-biphenyl-2-yloxy]-acetate
BDBM50085833 CHEMBL172144 Sodium; [5-(benzo[1,3]dioxol-5-ylmethoxy)-2-cyano-phenoxy]-o-tolyl-acetate
BDBM50121754 CHEMBL12488 amino[(2,4-dioxo-1,2,3,4-tetrahydrothieno[3,2-d]pyrimidin-7-yl)amino]methaniminium acetate
BDBM50129068 (R)-mandelate (R)-2-Hydroxy-2-phenylacetate (2R)-hydroxy(phenyl)acetate (R)-mandelic acid
BDBM50206173 CHEMBL241281 (E)-7-((3,4-dihydroisoquinolin-2(1H)-yl)methyleneamino)-1,2,3,4-tetrahydronaphthalen-1-yl acetate
BDBM50207968 CHEMBL223462 1-(2-(3-phenylpropanoyl)phenoxy)-3-(piperidin-1-yl)propan-2-yl acetate
BDBM50224132 ethyl-2-methyl-1-[4-(methylsulfonyl)phenyl]-5-(phenyl)-1H-pyrrol-3-acetate CHEMBL238031
BDBM50251902 CHEMBL479405 ethyl 2-(3-hydroxy-2-(2-(phenylsulfonyl)acetamido)-2,3-dihydrothiazol-4-yl)acetate
BDBM50305804 CHEMBL593268 4-(4-(4-(methylsulfonyl)phenyl)-2,5-dioxo-2,5-dihydrofuran-3-yl)phenyl acetate
BDBM50307022 4-(2-((Z)-3-(3,5-dibromo-4-hydroxyphenyl)-2-methoxyacrylamido)vinyl)phenyl acetate CHEMBL601642
BDBM50310260 Heptyl 2-(5-hydroxy-4-oxo-2-phenyl-4H-chromen-7-yloxy)acetate CHEMBL599524
BDBM50310266 Hexadecyl 2-(5-hydroxy-4-oxo-2-phenyl-4H-chromen-7-yloxy)acetate CHEMBL598307
BDBM50310267 Octadecyl 2-(5-hydroxy-4-oxo-2-phenyl-4H-chromen-7-yloxy)acetate CHEMBL597096
BDBM50310268 CHEMBL591495 Icosyl 2-(5-hydroxy-4-oxo-2-phenyl-4H-chromen-7-yloxy)acetate
BDBM50316381 Ethyl-2-((S)-3-((S)-2-aminopropanamido)-2,6-dioxopiperidin-1-yl)acetate hydrochloride CHEMBL1095917
BDBM50316390 CHEMBL1095914 Ethyl-2-((S)-3-((S)-2,6-diaminohexanamido)-2,6-dioxopiperidin-1-yl)acetate hydrochloride
BDBM50318060 CHEMBL1096050 7-(6-(nitrooxy)hexyloxy)-4-oxo-2-phenyl-4H-chromen-5-yl acetate
BDBM526286 US11186554, Compound 7 ethyl 2-[5-[2-(4-fluoroanilino)phenyl]tetrazol-2- yl]acetate
CHEMBL1093140 BDBM50315768 5-bromo-4-methoxy-2-(((1S)-2,2,5-trimethyl-6-methylenecyclohexyl)methyl)phenyl acetate
CHEMBL1097729 7-(4-(nitrooxy)butoxy)-4-oxo-2-phenyl-4H-chromen-5-yl acetate BDBM50318059
CHEMBL119069 ethyl [({hydroxy[(6-phenoxy-2H-chromen-3-yl)methyl]amino}carbonyl)amino]acetate BDBM50042522
CHEMBL194984 BDBM50173951 N-[(3S)-1-azabicyclo[2.2.2]oct-3-yl]-5-phenylthiophene-2-carboxamide acetate
CHEMBL240025 BDBM50206183 (E)-6-((benzyl(methyl)amino)methyleneamino)-2,3-dihydro-1H-inden-1-yl acetate
CHEMBL274649 amino[(2,4-dioxo-1,2,3,4-tetrahydrothieno[3,2-d]pyrimidin-6-yl)amino]methaniminium acetate BDBM50121758
CHEMBL373785 methyl 2-(4-(3-(4-acetyl-3-hydroxy-2-propylphenoxy)propoxy)phenoxy)acetate BDBM50189970
CHEMBL599618 BDBM50307798 4-Acetamidophenyl 2-(3-methyl-4-(2-(trifluoromethyl)pyridin-4-ylamino)benzamido)acetate
CHEMBL599728 Decyl 2-(5-hydroxy-4-oxo-2-phenyl-4H-chromen-7-yloxy)acetate BDBM50310263
CHEMBL603968 BDBM50310261 Octyl 2-(5-hydroxy-4-oxo-2-phenyl-4H-chromen-7-yloxy)acetate
Dodecyl 2-(5-hydroxy-4-oxo-2-phenyl-4H-chromen-7-yloxy)acetate BDBM50310264 CHEMBL598305
Ethyl 2-(2-((2S,3R)-2-amino-3-methylpentanamido)thiazol- 4-yl)acetate (7b) BDBM234431
Hexyl 2-(5-hydroxy-4-oxo-2-phenyl-4H-chromen-7-yloxy)acetate BDBM50310259 CHEMBL591213
Isopropyl-2-methyl-5-[4-(methylsulfonyl)phenyl]-1-phenyl-1H-pyrrole-3-acetate CHEMBL605820 BDBM50308732
N-[(3R)-1-azabicyclo[2.2.2]oct-3-yl]-5-phenylthiophene-2-carboxamide acetate BDBM50173956 CHEMBL370535
Nonyl 2-(5-hydroxy-4-oxo-2-phenyl-4H-chromen-7-yloxy)acetate CHEMBL599145 BDBM50310262
Sodium [5-hydroxy-5-(2-pentyloxy-quinolin-3-yl)-pent-2-ynyloxy]-acetate (18a) BDBM233180
Tetradecyl 2-(5-hydroxy-4-oxo-2-phenyl-4H-chromen-7-yloxy)acetate CHEMBL598306 BDBM50310265
US10266526, Compound 122 BDBM377994 ethyl 2-(2-oxoindoline-5-carboxamido)-2-(piperidin-4-yl)acetate
bisarylimidazole derivative, 1 methyl 2-[4-(4,5-diphenyl-1H-imidazol-1-yl)phenoxy]acetate BDBM26742
ethyl 2-(4-(pyridin-2-ylamino)-2-(3,4,5-trimethoxyphenylamino)pyrimidin-5-yl)acetate BDBM50181987 CHEMBL204933
ethyl 2-[1'-benzylspiro[3,4-dihydro-1H-isochromene-1,4'-(hexahydropyridine)]-3-yl]acetate BDBM50120473 CHEMBL148236
isopropyl 2-(4-benzyl-5-(2-methoxyphenyl)-4H-1,2,4-triazol-3-ylthio)acetate BDBM50296417 CHEMBL561592
methyl 2-(4-(5-(3-acetamidobut-1-ynyl)thiazol-2-yloxy)phenoxy)acetate BDBM50195030 CHEMBL220007
methyl 2-(4-benzyl-5-(2-hydroxyphenyl)-4H-1,2,4-triazol-3-ylthio)acetate CHEMBL563744 BDBM50296416
methyl 2-(4-chloro-2-(2-(3-(diisobutylcarbamoyl)-5-methylphenoxy)ethyl)phenoxy)acetate CHEMBL1682773 BDBM50337487
Methyl 2,3-Dihydro-l-methyl-2-thioxo-1H-indole-3-acetate methyl 2-(1-methyl-2-sulfanylidene-2,3-dihydro-1H-indol-3-yl)acetate 2-thioxo-1H-indole-3-alkanoic acid deriv. 8 BDBM3959
[4-[(phenylsulfonylhydrazinylidene)methyl]phenyl] ethanoate cid_875541 SMR000298281 acetic acid [4-[(benzenesulfonylhydrazinylidene)methyl]phenyl] ester BDBM57819 [4-[(benzenesulfonylhydrazinylidene)methyl]phenyl] acetate acetic acid [4-[(besylhydrazono)methyl]phenyl] ester 4-[2-(phenylsulfonyl)carbonohydrazonoyl]phenyl acetate MLS000673752
dithiobis(1H-indole-3-alkanoic acid) deriv. 22 BDBM3974 methyl 2-(2-{[3-(2-methoxy-2-oxoethyl)-1H-indol-2-yl]disulfanyl}-1H-indol-3-yl)acetate Dimethyl 2,2 -Dithiobis(1H-indole-3-acetate)
methyl 2-[2-({[3-(2-methoxy-2-oxoethyl)-1H-indol-2-yl]sulfanyl}disulfanyl)-1H-indol-3-yl]acetate Dimethyl 2,2 -Trithiobis(1H-indole-3-acetate) dithiobis(1H-indole-3-alkanoic acid) deriv. 26 BDBM3978
(R)-4-(4-(4-benzoyl-2-methylpiperazin-1-yl)phthalazin-1-yl)phenyl acetate CHEMBL1209189 BDBM50323132
(S)-Ethyl 2-(2-(2-(tert-butoxycarbonylamino)-4-(methylthio)butanamido)thiazol-4-yl) acetate (8a) BDBM234434
(S)-Methyl 2-(2-(2,6-dioxo-3-(3,4,5-trimethoxybenzamido)piperidin-1-yl)acetamido)acetate CHEMBL246179 BDBM50210541
16,17-dimethyl-13-methylcarbonyloxy-17-azatetracyclo[7.6.2.02,7.010,15]heptadeca-2(7),3,5,12,14-pentaen-4-yl acetate BDBM50122519
2-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-oxoethyl 2-(4-chlorobenzamido)acetate CHEMBL1172972 BDBM50322736
3-{[(1,1,2,2,3,3,4,4,4-nonafluorobutyl)sulphonyl]oxy}-17-oxooestra-1,3,5(10)-trien-11a-yl acetate BDBM264477 US9714266, 6
BDBM50084103 CHEMBL76530 Sodium; [(1S,3S)-1-hydroxy-3-((E)-3-hydroxy-oct-1-enyl)-cyclohexyl]-acetate
BDBM50168291 CHEMBL363350 Sodium; {3-[(S)-2-(4,5-diphenyl-oxazol-2-yl)-cyclopent-2-enylmethyl]-phenoxy}-acetate
BDBM50191134 sodium 2-(3-(((1S,2S)-2-(4,5-diphenyloxazol-2-yl)cyclopentyl)methyl)phenoxy)acetate CHEMBL379203
BDBM50191135 CHEMBL215442 sodium 2-(3-(((1S,2R)-2-(4,5-diphenyloxazol-2-yl)cyclopentyl)methyl)phenoxy)acetate
BDBM50191137 sodium 2-(3-(((1S,2R)-2-(4,5-diphenyloxazol-2-yl)cyclohexyl)methyl)phenoxy)acetate CHEMBL212943
BDBM50253831 CHEMBL505334 Methyl 2-(4-(4-Fluorophenyl)-5-(pyridin-4-yl)-1H-imidazole-2-ylthio)acetate
BDBM50263002 CHEMBL515637 (2-amino-2-oxoacetyl)-1-benzyl-2-ethyl-1H-6,7-benzoindol-4-yloxy)acetate
BDBM50265313 3-(4-(3-(bis(4-fluorophenyl)amino)propyl)piperazin-1-yl)-1-phenylpropyl acetate CHEMBL498600
BDBM50265487 2-(benzofuran-2-yl)-4-oxo-4H-benzo[d][1,3]oxazin-6-yl acetate CHEMBL498412
BDBM50273264 ethyl 2-(2-(2-(2-hydroxy-5-(N'-hydroxycarbamimidoyl)phenylsulfonamido)ethyl)-5-isopropylphenoxy)acetate CHEMBL457632
BDBM50322740 CHEMBL1173692 2-(4-chloro-2-(trifluoromethyl)phenylamino)-2-oxo-1-phenylethyl 2-(4-chlorobenzamido)acetate
BDBM50326569 methyl 2-(4-methyl-5-(thiophen-2-yl)-4H-1,2,4-triazol-3-ylthio)acetate CHEMBL1253492
BDBM50329093 (Z)-methyl 2-(2-oxo-2H-benzo[b][1,4]thiazin-3(4H)-ylidene)acetate CHEMBL1269474
CHEMBL1171525 BDBM50321533 methyl 2-(N-(2-(4-fluorobenzamido)-4-methoxybenzo[d]thiazol-7-yl)acetamido)acetate
CHEMBL1269380 (Z)-methyl 2-(2-oxo-2H-benzo[b][1,4]oxazin-3(4H)-ylidene)acetate BDBM50329094
CHEMBL148479 BDBM50055334 Sodium; [3-carbamoylmethyl-1-(3-chloro-benzyl)-2-methyl-1H-indol-4-yloxy]-acetate
CHEMBL1668289 2-bromo-4-((1-(4-bromophenyl)-3,5-dioxopyrazolidin-4-ylidene)methyl)-6-methoxyphenyl acetate BDBM50336422
CHEMBL1778904 BDBM50344615 Ethyl-(E)-2-(4-(3-(5-Bromo-4-hydroxy-2-methoxyphenyl)acryloyl)phenoxy)acetate
CHEMBL205071 ethyl 2-({N'-[(1E,2S)-2-{[(tert-butoxy)carbonyl]amino}hexylidene]hydrazinecarbonyl}amino)acetate BDBM50177507
CHEMBL214394 BDBM50189964 methyl 2-(2-methyl-4-(3-(2-propyl-4-(trifluoromethyl)phenoxy)propoxy)phenoxy)acetate
CHEMBL497598 BDBM50265470 (R)-tert-butyl 2-(3-(3-fluoro-4-hydroxyphenyl)-4,5-dihydroisoxazol-5-yl)acetate
DAGO ACETATE SALT BDBM82089 CAS_ 100929-53-1 D-Ala2-MePhe4-Met(0)5-enkephalin-ol
Ethyl 2-(2-((2S,3R)-2-(tert-butoxycarbonylamino)-3-methylpentanamido)thiazol-4-yl)acetate (5a) BDBM234422
Methyl 2-(4-((2-cyclopentyl-6-ethylpyrimidin-4-yl)methyl)phenyl)acetate US11401286, Example 223 BDBM562651
Sodium; (1-biphenyl-2-ylmethyl-3-carbamoylmethyl-2-methyl-1H-indol-4-yloxy)-acetate BDBM50055305 CHEMBL423762
Sodium; [(1S,3S)-1-hydroxy-3-((E)-3-hydroxy-undec-1-enyl)-cyclohexyl]-acetate CHEMBL80541 BDBM50084101
Sodium; [1-hydroxy-3-((E)-3-hydroxy-7-phenyl-hept-1-enyl)-cyclohexyl]-acetate BDBM50087682 CHEMBL354872
US11186554, Compound 18 BDBM526294 Ethyl 2-[4-[2-[3- (trifluoromethyl)anilino]phenyl]triazol-1- yl]acetate
US11220486, Compound I65 BDBM533135 ethyl 2-[(4-{4-[(3-piperidylpropyl)amino]-2- quinolyl}phenyl)carbonylamino]acetate
US8618147, 4 4-tert-butylphenyl 2-(3-(4-hydroxyphenyl)-4,5-dihydroisoxazol-5-yl)acetate BDBM50186432 CHEMBL211823
ethyl 2-((3R,5S)-4-(4-amino-3,5-dichlorobenzoyl)-3,5-dimethylpiperazin-1-yl)acetate CHEMBL222317 BDBM50195486
ethyl 2-(2-methyl-3,5-dioxo-1,2,4-thiadiazolidin-4-yl)acetate BDBM7852 Thiadiazolidinone (TDZD) deriv. 59
methyl 2-((1s,4s)-4-(4-amino-3,5-dichloro-N-cyclopropylbenzamido)-N-methylcyclohexanecarboxamido)acetate CHEMBL426208 BDBM50195498
methyl 2-(5-(4- phenylquinolin-2- yl)thiophen-2-yl)acetate US10995070, Formula IId-i BDBM495031
methyl 2-[(4-{4-[(3-piperidylpropyl)amino]-2- quinolyl}phenyl)carbonylamino]acetate US11220486, Compound I69 BDBM533139
n-Butyl-2-Methyl-5-[4-(methylsulfonyl)phenyl]-1-phenyl-1H-pyrrole-3-acetate BDBM50308736 CHEMBL602237
sodium 2-(3-(((1S,2S)-2-(4,5-diphenyloxazol-2-yl)cyclohexyl)methyl)phenoxy)acetate BDBM50191138 CHEMBL405770
(+)-Ethyl 2-[2-(2-benzoyl-5,6-dibromo-1H-benzo[d]imidazol-1-yl)pentanamido] acetate (Compound 22) BDBM115177 (−)-Ethyl 2-[2-(2-benzoyl-5,6-dibromo-1H-benzo[d]imidazol-1-yl)pentanamido]acetate (Compound 23)
BDBM50204955 methyl{[4-(benzoylamino)-5-({2-[(benzoyl)amino]-1,3-thiazol-4-yl}methyl)-4H-1,2,4-triazol-3-yl]sulfanyl}acetate CHEMBL388906 methyl 2-(4-benzamido-5-((2-benzamidothiazol-4-yl)methyl)-4H-1,2,4-triazol-3-ylthio)acetate
methyl 2-(5-((2-acetamidothiazol-4-yl)methyl)-4-benzamido-4H-1,2,4-triazol-3-ylthio)acetate BDBM50204979 methyl{[4-(benzoylamino)-5-({2-[(acetyl)amino]-1,3-thiazol-4-yl}methyl)-4H-1,2,4-triazol-3-yl]sulfanyl}acetate CHEMBL243704
((2E)-3-{4-[(3-bromophenyl)amino]quinazolin-6-yl}-1-methyltriaz-2-enyl)methyl acetate BDBM50136228 CHEMBL152922
(E)-7-((6,7-dimethoxy-3,4-dihydroisoquinolin-2(1H)-yl)methyleneamino)-1,2,3,4-tetrahydronaphthalen-1-yl acetate CHEMBL240022 BDBM50206165
(S)-Benzyl-2-(2-(3-((S)-2-amino-3-phenylpropanamido)-2,6-dioxopiperidin-1-yl))acetate BDBM50323943 CHEMBL1214593
(S)-ethyl 2-(3-((3-chloro-4-cyanophenyl)(2-chlorobenzyl)amino)pyrrolidin-1-yl)acetate CHEMBL559261 BDBM50298033
(S)-tert-butyl 2-(6-isopropyl-1-methyl-4,7-dioxo-1,3,5-triazepan-3-yl)acetate CHEMBL385572 BDBM50200325
2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4-oxo-4H-chromen-3-yl 2-(tert-butoxycarbonylamino)acetate CHEMBL564008 BDBM50293323
2-[1'-cyclooctylmethyl-2-oxospiro[2,3-dihydro-1H-indole-3,4'-(hexahydropyridine)]-1-yl]ethyl acetate BDBM50173253 CHEMBL373190
ATC [2-(acetylsulfanyl)ethyl]trimethylazanium iodide acetylthiocholine chloride Acetylthiocholine acetylthiocholine iodide (2-Mercaptoethyl)trimethylammonium iodide acetate BDBM8959
BDBM12415 copper(2+) ion 2-[(carboxylatomethyl)[(4-{[2-(4-sulfamoylphenyl)ethyl]carbamoyl}phenyl)methyl]amino]acetate BR15
BDBM19959 3-arylquinazolinethione, 1bg 5-(acetyloxy)-3-[4-(acetyloxy)phenyl]-4-sulfanylidene-3,4-dihydroquinazolin-7-yl acetate
BDBM226160 Ethyl 2-(6-chloro-3-(4-methoxyphenyl)-4-oxo-3,4-dihydroquinazolin-2-yl-thio)acetate (12)
BDBM325773 US9636339, 23 (rac)-Ethyl 2-[4-[2-fluoro-4-(trifluoromethyl)phenyl]-5,6,7,8-tetrahydroisoquinolin-8-yl]acetate
BDBM426839 US10544113, No. 68 Methyl {4-[2-(4-fluorophenyl)-4-oxo-1,3-thiazolidin-3-yl]-3-methylphenoxy}acetate
BDBM50173270 methyl 2-[1'-cyclododecylmethyl-2-oxospiro[2,3-dihydro-1H-indole-3,4'-(hexahydropyridine)]-1-yl]acetate CHEMBL370782
BDBM50184038 CHEMBL206927 methyl 2-(2-(2-(3,4,5-trimethoxyphenylamino)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)picolinamido)acetate
BDBM50191133 sodium (R)-2-(3-((2-(4,5-diphenyloxazol-2-yl)pyrrolidin-1-yl)methyl)phenoxy)acetate CHEMBL439357
BDBM50193604 CHEMBL214020 (E)-4-(3-(4-amino-2-propylquinolin-6-ylamino)-3-oxoprop-1-enyl)phenyl acetate
BDBM50221687 CHEMBL392116 2-(1,3-dimethyl-2,4-dioxo-1,2,3,4,7,8-hexahydropyrimido[1,2-a]purin-9(6H)-yl)-1-phenylethyl acetate
BDBM50224122 ethyl-2-methyl-5-[4-(methylsulfonyl)phenyl]-1-[4-(methoxy)phenyl]-1H-pyrrol-3-acetate CHEMBL398382
BDBM50224124 ethyl-2-methyl-1-[4-(methylsulfonyl)phenyl]-5-[4-(methoxy)phenyl]-1H-pyrrol-3-acetate CHEMBL237813
BDBM50224126 CHEMBL398383 Ehyl-2-methyl-1-[4-(methylsulfonyl)phenyl]-5-[3,4-(difluoro)phenyl]-1H-pyrrol-3-acetate
BDBM50226640 CHEMBL400428 phenylmethyl 2-{6-chloro-1-[(4-chlorophenyl)carbonyl]-5-methoxy-2-methylindol-3-yl}acetate
BDBM50235096 methyl 2-(2-(2-phenylbicyclo[2.2.1]heptan-2-yl)-5-(quinolin-2-ylmethoxy)phenoxy)acetate CHEMBL255011
BDBM50263039 CHEMBL514365 tert-Butyl [8-carbamoyl-7-(3,5-dimethoxyphenylamino)-1,2,4-triazolo[4,3-c]pyrimidin-5-ylamino]acetate
BDBM50263445 ethyl 2-cyano-2-(3-ethyl-5-((2-fluorophenylamino)methylene)-4-oxothiazolidin-2-ylidene)acetate CHEMBL476137
BDBM50263587 propyl 2-cyano-2-(3-ethyl-5-((4-hydroxyphenylamino)methylene)-4-oxothiazolidin-2-ylidene)acetate CHEMBL477615
BDBM50263874 ethyl 2-(5-methyl-7-oxo-3-phenyl-4,7-dihydropyrazolo[1,5-a]pyrimidin-6-yl)acetate CHEMBL1608283
BDBM50271143 (3R,4R)-(-)-6-methoxy-1-oxo-3-pentyl-3,4-dihydro-1H-isochromen-4-yl acetate CHEMBL529220
BDBM50296145 ethyl 2-(6-bromo-2-(4-fluorophenyl)-4-phenyl-1,2-dihydroquinazolin-3(4H)-yl)acetate CHEMBL555341
BDBM50316382 Ethyl-2-((S)-3-((S)-2-amino-3-methylbutanamido)-2,6-dioxopiperidin-1-yl)acetate hydrochloride CHEMBL1095918
BDBM50316383 CHEMBL1097230 Ethyl-2-((S)-3-((S)-2-amino-4-methylpentanamido)-2,6-dioxopiperidin-1-yl)acetate hydrochloride
BDBM50336425 2-methoxy-4-((2-(naphthalen-2-yl)-5-oxooxazol-4(5H)-ylidene)methyl)phenyl acetate CHEMBL1668292
BDBM50341272 (Z)-Methyl-2-(4-(5-(4-methoxybenzylidene)-4-oxo-4,5-dihydrothiazol-2-yl)phenoxy)acetate CHEMBL1765902
CHEMBL1085975 BDBM50320052 ethyl 2-(4-(benzyloxy)-3-((S)-3-cyclohexyl-2-(4-methylbenzamido)propanamido)-2-oxobutanamido)acetate
CHEMBL1085976 ethyl 2-(4-(benzyloxy)-3-((S)-3-cyclohexyl-2-(2,3-difluorobenzamido)propanamido)-2-oxobutanamido)acetate BDBM50320053
CHEMBL1095500 BDBM50316987 3,3-Dimethylbutyl 2-(1-(4-Chlorobenzoyl)-5-methoxy-2-methyl-1H-indol-3-yl)acetate
CHEMBL1254438 BDBM50327140 (R)-methyl 2-(4-(hydroxymethoxy)-3-(hydroxymethyl)phenyl)-2-((R)-1-methylpiperidin-2-yl)acetate
CHEMBL148629 BDBM22979 methyl 2-({2-[(2,6-dichloro-3-methylphenyl)amino]phenyl}formamido)acetate Meclofenamic acid derivative, 31
CHEMBL1683479 BDBM50337759 ethyl 2-(3-((R)-3-amino-4-(2,4,5-trifluorophenyl)butanoyl)thiazolidine-2-carboxamido)acetate hydrochloride
CHEMBL1766544 Ethyl 2-(4-(5-(3-nitrobenzylamino)-7-(trifluoromethyl)quinolin-3-yl)piperazin-1-yl)acetate BDBM50341648
CHEMBL198099 methyl 2-[1'-cyclohexylmethyl-2-oxospiro[2,3-dihydro-1H-indole-3,4'-(hexahydropyridine)]-1-yl]acetate BDBM50173261
CHEMBL237402 phenylmethyl 2-{4-chloro-1-[(4-chlorophenyl)carbonyl]-5-methoxy-2-methylindol-3-yl}acetate BDBM50226658
CHEMBL237626 ethyl-2-methyl-5-[4-(methylsulfonyl)phenyl]-1-[4-(fluoro)-phenyl]-1H-pyrrol-3-acetate BDBM50224129
CHEMBL239016 2-(1,3-dimethyl-2,4-dioxo-1,2,3,4,7,8-hexahydropyrimido[1,2-a]purin-9(6H)-yl)-1-phenylpropyl acetate BDBM50221689
CHEMBL241103 BDBM50206178 (E)-6-((3,4-dihydroisoquinolin-2(1H)-yl)methyleneamino)-2,3-dihydro-1H-inden-1-yl acetate
CHEMBL256765 methyl 2-(3-(2-phenylbicyclo[2.2.1]heptan-2-yl)-4-(quinolin-2-ylmethoxy)phenoxy)acetate BDBM50235118
CHEMBL404266 methyl 2-(2-(2-phenylbicyclo[2.2.1]heptan-2-yl)-4-(quinolin-2-ylmethoxy)phenoxy)acetate BDBM50235094
CHEMBL427010 methyl 2-[1'-cycloheptylmethyl-2-oxospiro[2,3-dihydro-1H-indole-3,4'-(hexahydropyridine)]-1-yl]acetate BDBM50173284
CHEMBL434944 methyl 2-[1'-cyclooctylmethyl-2-oxospiro[2,3-dihydro-1H-indole-3,4'-(hexahydropyridine)]-1-yl]acetate BDBM50173254
CHEMBL438092 sodium (S)-2-(3-((2-(4,5-diphenyloxazol-2-yl)pyrrolidin-1-yl)methyl)phenoxy)acetate BDBM50191132
CHEMBL571219 BDBM50301055 4-(3-(2,4-dimethoxy-5-(2-methylbut-3-en-2-yl)phenyl)acryloyl)phenyl acetate
CHEMBL589812 Isopropyl-2-methyl-5-[4-(methylsulfonyl)phenyl]-1-[3-(fluoro)phenyl]-1H-pyrrol-3-acetate BDBM50308734
CHEMBL589813 BDBM50308738 Isopropyl-2-methyl-5-[4-(methylsulfonyl)phenyl]-1-[3,4-(difluoro)phenyl]-1H-pyrrol-3-acetate
Ethyl 2-(4-((2-(3-chlorophenyl)-6-ethylpyrimidin-4-yl)amino)phenyl)acetate US11401286, Example 185 BDBM562613
Ethyl 2-(6,7-dimethoxy-3-(4-methoxyphenyl)-4-oxo-3,4-dihydroquinazolin-2-yl-thio)acetate (13) BDBM226161
Ethyl-2-((S)-2,6-dioxo-3-((S)-pyrrolidine-2-carboxamido)piperidin-1-yl)acetate hydrochloride BDBM50316391 CHEMBL1096255
Isopropyl-2-methyl-5-[4-(methylsulfonyl)phenyl]-1-[4-(methoxy)phenyl]-1H-pyrrol-3-acetate CHEMBL600167 BDBM50308740
US11220486, Compound I258 3-{4-[(3-piperidylpropyl)amino]-2- quinolyl]phenyl)methyl acetate US11220486, Compound I79 BDBM533149
US11401286, Example 208 BDBM562636 Methyl 2-(4-((2-(3-chlorophenyl)-6-cyclopropylpyrimidin-4-yl)methyl)phenyl)acetate
ethyl 2-{4-[2-(naphthalene-1-amido)-4-phenylphenyl]piperazin-1-yl}acetate BDBM16731 Naphthyl Compound, 5b
ethyl-2-Methyl-1-[4-(methylsulfonyl)phenyl]-5-[4-(fluoro)-phenyl]-1H-pyrrol-3-acetate BDBM50224113 CHEMBL237811
ethyl-2-Methyl-1-[4-(methylsulfonyl)phenyl]-5-[4-(trifluoro)phenyl]-1H-pyrrol-3-acetate CHEMBL238033 BDBM50224115
ethyl-2-methyl-1-[4-(methylsulfonyl)phenyl]-5-[4-(methyl)phenyl]-1H-pyrrol-3-acetate CHEMBL398384 BDBM50224127
ethyl-2-methyl-5-[4-(methylsulfonyl)phenyl]-1-[3,4-(difluoro)phenyl]-1H-pyrrol-3-acetate CHEMBL238027 BDBM50224128
ethyl-2-methyl-5-[4-(methylsulfonyl)phenyl]-1-[3-(fluoro)phenyl]-1H-pyrrol-3-acetate BDBM50224118 CHEMBL237592
methyl 2-(4-(3-(6-acetyl-5-hydroxy-4-propylpyridin-3-yloxy)propoxy)phenoxy)acetate CHEMBL212993 BDBM50189968
methyl 2-[1'-hexyl-2-oxospiro[2,3-dihydro-1H-indole-3,4'-(hexahydropyridine)]-1-yl]acetate CHEMBL198167 BDBM50173263
sodium-2-(3-((5-oxo-3,4-diphenyl-1H-pyrrol-2(5H)-ylidene)methyl)phenoxy)acetate CHEMBL603204 BDBM50305683
(+)-Ethyl 2-[2-(2-benzoyl-5,6-dibromo-1H-benzo[d]imidazol-1-yl)-2 cyclopropylacetamido] acetate (Compound 20) BDBM115175 (−)-Ethyl 2-[2-(2-benzoyl-5,6-dibromo-1H-benzo[d]imidazol-1-yl)-2 cyclopropylacetamido] acetate (Compound 21)
methyl 2-(5-((2-acetamidothiazol-4-yl)methyl)-4-(4-chlorobenzamido)-4H-1,2,4-triazol-3-ylthio)acetate BDBM50205070 methyl{[4-(benzoylamino)-5-({2-[(acetyl)amino]-1,3-thiazol-4-yl}methyl)-4H-1,2,4-triazol-3-yl]sulfanyl}acetate CHEMBL232522
methyl{[4-(benzoylamino)-5-({2-[(benzoyl)amino]-1,3-thiazol-4-yl}methyl)-4H-1,2,4-triazol-3-yl]sulfanyl}acetate methyl 2-(5-((2-benzamidothiazol-4-yl)methyl)-4-(4-chlorobenzamido)-4H-1,2,4-triazol-3-ylthio)acetate CHEMBL399387 BDBM50205039
BDBM75034 SMR000338123 methyl 2-[4,5-dimethoxy-2-(methylsulfamoyl)phenyl]acetate cid_3365444 2-[4,5-dimethoxy-2-(methylsulfamoyl)phenyl]acetic acid methyl ester methyl 2-[4,5-dimethoxy-2-(methylsulfamoyl)phenyl]ethanoate methyl 2-{4,5-dimethoxy-2-[(methylamino)sulfonyl]phenyl}acetate MLS000755263
SMR000476349 MLS001179149 cid_878744 BDBM69626 acetic acid (3-benzoylbenzofuran-5-yl) ester acetic acid (3-benzoyl-5-benzofuranyl) ester (3-benzoyl-1-benzofuran-5-yl) acetate 3-benzoyl-1-benzofuran-5-yl acetate [3-(phenylcarbonyl)-1-benzofuran-5-yl] ethanoate
methyl 2-(4-benzamido-5-((2-(2-chloroacetamido)thiazol-4-yl)methyl)-4H-1,2,4-triazol-3-ylthio)acetate BDBM50205043 CHEMBL244081 methyl{[4-(benzoylamino)-5-({2-[(chloroacetyl)amino]-1,3-thiazol-4-yl}methyl)-4H-1,2,4-triazol-3-yl]sulfanyl}acetate
(R)-methyl 2- (2-chlorophenyl)-2- (5H-chromeno [3,4-c]pyridine-8- carboxamido)acetate US9914740, II-15 BDBM376299
(Z)-methyl 2-(5-methyl-2-oxo-2H-benzo[b][1,4]oxazin-3(4H)-ylidene)acetate CHEMBL1269381 BDBM50329082
(Z)-methyl 2-(7-nitro-2-oxo-2H-benzo[b][1,4]oxazin-3(4H)-ylidene)acetate CHEMBL1269432 BDBM50329091
17-cyclopropylmethyl-16-methyl-13-methylcarbonyloxy-17-azatetracyclo[7.6.2.02,7.010,15]heptadeca-2(7),3,5,12,14-pentaen-4-yl acetate BDBM50122526
BDBM12416 copper(2+) ion 2-[(carboxylatomethyl)({[(3-{[2-(4-sulfamoylphenyl)ethyl]carbamoyl}phenyl)carbamoyl]methyl})amino]acetate BR22
BDBM261670 US9708279, 47 isopropyl 2-((4-((4-(3-((triisopropylsilyl)ethynyl)phenyl)thiazol-2-yl)carbamoyl)benzyl)amino)acetate
BDBM327226 ethyl {[4-chloro-2-({[4-chloro-3-(trifluoromethyl)phenyl]sulfonyl}amino)phenyl]-sulfinyl}acetate US9663460, Example 13
BDBM357839 Step 1: Preparation of 5-bromo-6-chloro-3-(p-tolylethynyl)pyridin-2-yl acetate US10214534, Compound 6002
BDBM377975 US10266526, Compound 104 ethyl 2-(1-(L-alanyl)piperidin-4-yl)-2-(2-oxoindoline-5-carboxamido)acetate
BDBM411200 US10385022, Example 196 Methyl 2-(N-(4-(2-fluorophenyl)pyridin-3-yl)-2,6-bis(trifluoromethyl)isonicotinamido)acetate
BDBM50084106 Sodium; [(1S,3S)-1-hydroxy-3-((E)-3-hydroxy-7-phenyl-hept-1-enyl)-cyclohexyl]-acetate CHEMBL77513
BDBM50087681 CHEMBL164721 Sodium; {3-[(E)-7-(4-azido-phenyl)-3-hydroxy-hept-1-enyl]-1-hydroxy-cyclohexyl}-acetate
BDBM50173260 methyl 2-[1'-(4-methoxycyclohexylcarbonyl)-2-oxospiro[2,3-dihydro-1H-indole-3,4'-(hexahydropyridine)]-1-yl]acetate CHEMBL440038
BDBM50173271 methyl 2-[1'-(2-naphthylmethyl)-2-oxospiro[2,3-dihydro-1H-indole-3,4'-(hexahydropyridine)]-1-yl]acetate CHEMBL444620
BDBM50173280 methyl 2-[1'-(1-naphthylmethyl)-2-oxospiro[2,3-dihydro-1H-indole-3,4'-(hexahydropyridine)]-1-yl]acetate CHEMBL198678
BDBM50173282 methyl 2-[1'-(2-butyloctyl)-2-oxospiro[2,3-dihydro-1H-indole-3,4'-(hexahydropyridine)]-1-yl]acetate CHEMBL382086
BDBM50192125 CHEMBL385052 methyl 2-(2-(ethyl(4-(1,1,1,3,3,3-hexafluoro-2-hydroxypropan-2-yl)phenyl)amino)-2-phenylethoxy)acetate
BDBM50205050 CHEMBL391674 methyl 2-(4-acetamido-5-((2-benzamidothiazol-4-yl)methyl)-4H-1,2,4-triazol-3-ylthio)acetate
BDBM50205509 (R,R)-(+)-ethyl {4-[2-{[2-(3-bromoisoxazol-5-yl)-2-hydroxyethyl]amino}propyl]phenoxy} acetate CHEMBL226348
BDBM50209248 (S)-ethyl 2-(1-(naphthalen-2-ylsulfonyl)-N-(1-phenethylpiperidin-4-yl)pyrrolidine-2-carboxamido)acetate CHEMBL428224
BDBM50308739 CHEMBL589087 n-Butyl-2-methyl-5-[4-(methylsulfonyl)phenyl]-1-[3,4-(difluoro)phenyl]-1H-pyrrol-3-acetate
BDBM50316384 Ethyl-2-((S)-3-((2S,3R)-2-amino-3-methylpentanamido)-2,6-dioxopiperidin-1-yl)acetate hydrochloride CHEMBL1097593
BDBM50320057 CHEMBL1083620 ethyl 2-(4-(benzyloxy)-3-((S)-2-(5-bromofuran-2-carboxamido)-3-cyclohexylpropanamido)-2-oxobutanamido)acetate
BDBM50329086 CHEMBL1269409 (Z)-methyl 2-(6-nitro-2-oxo-2H-benzo[b][1,4]oxazin-3(4H)-ylidene)acetate
BDBM50329087 (Z)-methyl 2-(6-(ethylsulfonyl)-2-oxo-2H-benzo[b][1,4]oxazin-3(4H)-ylidene)acetate CHEMBL1270877
BDBM50329088 CHEMBL1269410 (Z)-methyl 2-(7-methyl-2-oxo-2H-benzo[b][1,4]oxazin-3(4H)-ylidene)acetate
BDBM50329089 (Z)-methyl 2-(7-fluoro-2-oxo-2H-benzo[b][1,4]oxazin-3(4H)-ylidene)acetate CHEMBL1269430
BDBM50331083 CHEMBL1290362 ethyl 2-(3-methyl-7-(3-methylbenzyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-ylthio)acetate
BDBM50341271 (Z)-Methyl-2-(4-((4-oxo-2-(p-tolyl)-4H-thiazol-5-ylidene)methyl)phenoxy)acetate CHEMBL1765901
BDBM526330 ethyl 2-(4-(2-((4- (trifluoromethyl)phenyl)amino)phenyl)-1H- pyrazol-1-yl)acetate US11186554, Compound 60
BDBM526419 ethyl 2-(4-(2-((4- (trifluoromethyl)phenyl)amino)phenyl)-1H- imidazol-1-yl)acetate US11186554, Compound 202
Benzthiazole compound, 33o [(1-{[4-(1,3-benzothiazol-2-yloxy)phenyl]methyl}piperidin-4-yl)carbamoyl]methyl acetate BDBM24237
CHEMBL1085977 ethyl 2-((S)-4-(benzyloxy)-3-((S)-3-cyclohexyl-2-(2,5-difluorobenzamido)propanamido)-2-oxobutanamido)acetate BDBM50320054
CHEMBL1095501 BDBM50316986 2-(Trimethylsilyl)ethyl 2-(1-(4-Chlorobenzoyl)-5-methoxy-2-methyl-1H-indol-3-yl)acetate
CHEMBL1269382 BDBM50329083 (Z)-methyl 2-(6-methyl-2-oxo-2H-benzo[b][1,4]oxazin-3(4H)-ylidene)acetate
CHEMBL1269407 BDBM50329084 (Z)-methyl 2-(6-fluoro-2-oxo-2H-benzo[b][1,4]oxazin-3(4H)-ylidene)acetate
CHEMBL1269408 BDBM50329085 (Z)-methyl 2-(6-chloro-2-oxo-2H-benzo[b][1,4]oxazin-3(4H)-ylidene)acetate
CHEMBL1269431 (Z)-methyl 2-(7-chloro-2-oxo-2H-benzo[b][1,4]oxazin-3(4H)-ylidene)acetate BDBM50329090
CHEMBL232270 BDBM50204965 methyl 2-(4-acetamido-5-((2-acetamidothiazol-4-yl)methyl)-4H-1,2,4-triazol-3-ylthio)acetate
CHEMBL252843 3-(acetylthio)-4-(N-((2-amino-6-methylpyridin-3-yl)methyl)formamido)pent-3-enyl acetate BDBM50230591
CHEMBL373222 BDBM50173248 methyl 2-[1'-(4-chlorobenzyl)-2-oxospiro[2,3-dihydro-1H-indole-3,4'-(hexahydropyridine)]-1-yl]acetate
CHEMBL387852 BDBM50205510 (S,R)-(-)-ethyl {4-[2-{[2-(3-bromoisoxazol-5-yl)-2-hydroxyethyl]amino}propyl]phenoxy} acetate
CHEMBL448790 BDBM50190426 methyl [3-chloro-4-(3-{[5-(1,2-dithiolan-3-yl)pentanoyl](methyl)amino}propoxy)phenyl]acetate
CHEMBL491398 methyl 2-(3-(4-bromophenyl)-7-oxo-2-(trifluoromethyl)-4,7-dihydropyrazolo[1,5-a]pyrimidin-5-yl)acetate BDBM50263927
CHEMBL494514 BDBM50253311 N-{2-[(4-Carbamimidoylphenoxy)methyl]-2,4-dimethyl-3,4-dihydro-2H-1,4-benzoxazin-7-yl}benzamide acetate
CHEMBL508974 (R)-ethyl 2-(3-((5-(4-hydroxybenzylamino)-4-(2,2-diphenylacetamido)-5-oxopentylamino)(amino)methylene)ureido)acetate BDBM50246649
CHEMBL522486 Methyl 2-(4-(4-Fluorophenyl)-5-(2-(isopropylamino)pyridin-4-yl)-1H-imidazol-2-ylthio)acetate BDBM50253503
CHEMBL562831 BDBM50295994 ethyl 2-(6-(2-(5-ethyl-4-methyloxazol-2-yl)ethyl)-4-morpholinopyridin-2-ylamino)acetate
CHEMBL600844 BDBM50308737 n-Butyl-2-methyl-5-[4-(methylsulfonyl)phenyl]-1-[3-(fluoro)phenyl]-1H-pyrrol-3-acetate
Ethyl 2-[1-methyl-6-[(1-methylcyclopropyl)sulfamoyl]-2,4-dioxo-quinazolin-3-yl]acetate BDBM371360 US10239843, Example 468
Ethyl 2-[2-(2-benzyl-5,6-dichloro-1H-benzo[d]imidazol-1-yl)pentanamido] acetate (Compound 9) BDBM115164
Ethyl-2-((S)-3-((S)-2-amino-3-phenylpropan amido)-2,6-dioxopiperidin-1-yl)acetate hydrochloride CHEMBL1098915 BDBM50316385
Trifluoro-acetate(S)-1-((1S,2S)-1-cyano-2-phenyl-cyclopropylcarbamoyl)-2-(2-fluoro-phenyl)-ethyl-ammonium BDBM50269858
US11186554, Compound 76 ethyl 2-[3-methyl-4-[2-[4- (trifluoromethyl)anilino]phenyl]pyrazol-1- yl]acetate BDBM526336
US11401286, Example 203 BDBM562631 Methyl 2-(4-((2-(3-chlorophenyl)-6-(trifluoromethyl)pyrimidin-4-yl)methyl)phenyl)acetate
[2-[(5-(4-Chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazol-3-yl]methoxy]methyl acetate (14a) BDBM234288
ethyl 2-(4-((4-methyl-2-propyl-1H-benzo[d]imidazol-1-yl)methyl)phenoxy)acetate BDBM50303983 CHEMBL565793
ethyl 2-(4-(2-((3- (trifluoromethyl)phenyl)amino)phenyl)-1H- pyrazol-1-yl)acetate US11186554, Compound 58 BDBM526329
ethyl 2-[5-methyl-4-[2-[4- (trifluoromethyl)anilino]phenyl]pyrazol-1- yl]acetate US11186554, Compound 77 BDBM526337
ethyl {7-[(cyclohexylamino)carbonyl]-1-oxo-1,6,7,7a-tetrahydro-3a,6-epoxyisoindol-2-yl}acetate cid_3237886 MLS000092025 BDBM62672 SMR000026549
methyl 2-(4-(2-(4-(quinolin-2-ylmethoxy)phenyl)bicyclo[2.2.1]heptan-2-yl)phenoxy)acetate BDBM50235113 CHEMBL258215
methyl-2-(3-(benzo[d][1,3]dioxol-5-yl)-2-oxo-1-pentylindolin-3-yl)acetate BDBM50344860 CHEMBL1780052
n-Butyl-2-methyl-5-[4-(methylsulfonyl)phenyl]-1-[4-(methoxy)phenyl]-1H-pyrrol-3-acetate CHEMBL589166 BDBM50308741
BDBM50205071 CHEMBL232320 methyl 2-(5-((2-(2-chloroacetamido)thiazol-4-yl)methyl)-4-(4-chlorobenzamido)-4H-1,2,4-triazol-3-ylthio)acetate methyl{[4-(benzoylamino)-5-({2-[(2-chloroacetyl)amino]-1,3-thiazol-4-yl} methyl)-4H-1,2,4-triazol-3-yl]sulfanyl}acetate
Dimethyl 2,2 -Dithiobis(1-methyl-1H-indole-3-acetate) methyl 2-(2-{[3-(2-methoxy-2-oxoethyl)-1-methyl-1H-indol-2-yl]disulfanyl}-1-methyl-1H-indol-3-yl)acetate dithiobis(1H-indole-3-alkanoic acid) deriv. 23 BDBM3975
Dimethyl 2,2 -Thiobis(1-methyl-1H-indole-3-acetate) dithiobis(1H-indole-3-alkanoic acid) deriv. 24 BDBM3976 methyl 2-(2-{[3-(2-methoxy-2-oxoethyl)-1-methyl-1H-indol-2-yl]sulfanyl}-1-methyl-1H-indol-3-yl)acetate
methyl 2-[4-[(2-methylsulfanylphenyl)sulfamoyl]phenoxy]acetate MLS000097217 methyl [4-({[2-(methylthio)phenyl]amino}sulfonyl)phenoxy]acetate SMR000076824 2-[4-[[2-(methylthio)phenyl]sulfamoyl]phenoxy]acetic acid methyl ester methyl 2-[4-[(2-methylsulfanylphenyl)sulfamoyl]phenoxy]ethanoate cid_2208882 BDBM55301
(+/-)-Ethyl-[2-ethoxy-2-[-2-methyl-5-(4-methylsulfonyl)-phenyl-1-phenyl-1H-pyrrol-3-yl]]acetate BDBM50253566 CHEMBL522166
(+/-)-Ethyl-[2-hydroxy-2-[2-methyl-5-(4-methylsulfonyl)-phenyl-1-phenyl-1H-pyrrol-3-yl]]acetate CHEMBL523720 BDBM50253352
(1-(2-Chlorobenzyl)-1H-1,2,3-triazol-4-yl)methyl 2-(2-oxo-2H-chromen-4-yloxy)acetate (8k) BDBM167925
(1-(2-Fluorobenzyl)-1H-1,2,3-triazol-4-yl)methyl 2-(2-oxo-2H-chromen-4-yloxy)acetate (8h) BDBM167922
(1-(2-Nitrobenzyl)-1H-1,2,3-triazol-4-yl)methyl 2-(2-oxo-2H-chromen-4-yloxy)acetate (8n) BDBM167928
(1-(3-Fluorobenzyl)-1H-1,2,3-triazol-4-yl)methyl 2-(2-oxo-2H-chromen-4-yloxy)acetate (8i) BDBM167923
(1-(4-Chlorobenzyl)-1H-1,2,3-triazol-4-yl)methyl 2-(2-oxo-2H-chromen-4-yloxy)acetate (8m) BDBM167927
(1-(4-Fluorobenzyl)-1H-1,2,3-triazol-4-yl)methyl 2-(2-oxo-2H-chromen-4-yloxy)acetate (8j) BDBM167924
(1-(4-Methylbenzyl)-1H-1,2,3-triazol-4-yl)methyl 2-(2-oxo-2H-chromen-4-yloxy)acetate (8g) BDBM167921
(1-Benzyl-1H-1,2,3-triazol-4-yl)methyl 2-((2-oxo-2H-chromen-4-yl)oxy)acetate (8p) BDBM167930
(E)-6-((6,7-dimethoxy-3,4-dihydroisoquinolin-2(1H)-yl)methyleneamino)-2,3-dihydro-1H-inden-1-yl acetate BDBM50206174 CHEMBL241102
2-(3-cyano-4,5,6,7-tetrahydrobenzo[b]thiophen-2-ylamino)-2-oxoethyl 2-(4,6-diphenylpyrimidin-2-ylthio)acetate BDBM50346136 CHEMBL1782320
BDBM115167 Ethyl 2-[2-(2-benzyl-5,6-dibromo-1H-benzo[d]imidazol-1-yl)-2-cyclopropylacetamido] acetate (Compound 12)
BDBM115178 (−)-Ethyl 2-[2-(2-benzoyl-5,6-dibromo-1H-benzo[d]imidazol-1-yl)pentanamido]acetate (Compound 23)
BDBM14609 N-pyrazinylurea Analog 8d [(2-chloro-4-{[(5-cyanopyrazin-2-yl)carbamoyl]amino}-5-methoxyphenyl)carbamoyl]methyl acetate
BDBM167915 (1-(2-Bromobenzyl)-1H-1,2,3-triazol-4-yl)methyl 2-(2-oxo-2H-chromen-4-yloxy)acetate (8a)
BDBM167916 (1-(3-Bromobenzyl)-1H-1,2,3-triazol-4-yl)methyl 2-(2-oxo-2H-chromen-4-yloxy)acetate (8b)
BDBM167917 (1-(4-Bromobenzyl)-1H-1,2,3-triazol-4-yl)methyl 2-(2-oxo-2H-chromen-4-yloxy)acetate (8c)
BDBM167918 (1-(3-Methoxybenzyl)-1H-1,2,3-triazol-4-yl)methyl 2-(2-oxo-2H-chromen-4-yloxy)acetate (8d)
BDBM167919 (1-(4-Methoxybenzyl)-1H-1,2,3-triazol-4-yl)methyl 2-(2-oxo-2H-chromen-4-yloxy)acetate (8e)
BDBM167920 (1-(2-Methylbenzyl)-1H-1,2,3-triazol-4-yl)methyl 2-(2-oxo-2H-chromen-4-yloxy)acetate (8f)
BDBM167929 (1-(4-Nitrobenzyl)-1H-1,2,3-triazol-4-yl)methyl 2-(2-oxo-2H-chromen-4-yloxy)acetate (8o)
BDBM312594 US9604989, Example 80 Methyl ({2-[4-(1-aminocyclobutyl)phenyl]-3-phenylimidazo[1,2-b]pyridazin-6-yl}oxy)acetate
BDBM355315 US9815796, Example 406 methyl {[(6-oxo-2-phenyl-1,6- dihydropyrimidin-4- yl)carbonyl]amino}[4- (trifluoromethyl)phenyl]acetate
BDBM391966 Ethyl [2-({[(4- Bromophenyl)carbamoyl] amino}methyl)-1H- imidazol-1-yl]acetate US10301269, Number 11 US10800744, Number 11
BDBM432531 US10577363, Compound 231 ethyl 2-(((2S,4S)-4-(5- cyclopropylisoxazole-3-carboxamido)-2- methylpiperidin-1-yl)sulfonyl)acetate
BDBM432552 US10577363, Compound 252 ethyl 2-(((2R,4R)-4-(5- cyclopropylisoxazole-3-carboxamido)-2- methylpiperidin-1-yl)sulfonyl)acetate
BDBM432620 ethyl 2-(((2R,4S)-4-(5- cyclopropylisoxazole-3-carboxamido)-2- methylpiperidin-1-yl)sulfonyl)acetate US10577363, Compound 320
BDBM50106088 CHEMBL99888 Lithium; (R)-((S)-5-methyl-3-{2-[4-(3-o-tolyl-ureido)-phenyl]-acetylamino}-hexanoylamino)-phenyl-acetate
BDBM50173249 methyl 2-[2-oxo-1'-(4-trifluoromethylbenzyl)spiro[2,3-dihydro-1H-indole-3,4'-(hexahydropyridine)]-1-yl]acetate CHEMBL197880
BDBM50183976 CHEMBL207232 methyl 2-(2-(3-(2-(3,4,5-trimethoxyphenylamino)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)phenyl)acetamido)acetate
BDBM50183987 methyl 2-(3-(3-(2-(3,4,5-trimethoxyphenylamino)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)phenyl)propanamido)acetate CHEMBL382192
BDBM50219109 1-(4-(2,3-dichlorophenyl)piperazin-1-yl)-4-(4-(pyridin-2-yl)-benzamido)butan-2-yl acetate CHEMBL242434
BDBM50253500 CHEMBL492264 Methyl 2-(4-(4-Fluorophenyl)-5-(2-(1-phenylethylamino)pyridin-4-yl)-1H-imidazol-2-ylthio)acetate
BDBM50263693 ethyl 2-cyano-2-(3-ethyl-5-((4-(2-methoxyacetamido)phenylamino)methylene)-4-oxothiazolidin-2-ylidene)acetate CHEMBL516582
BDBM50266190 ethyl 2-(3,5-dioxo-4-(2-oxo-2-(piperidin-1-yl)ethyl)-1,2,4-thiadiazolidin-2-yl)acetate CHEMBL458210
BDBM50315262 Methyl{4-[(6-amino-2-butoxy-8-oxo-7,8-dihydro-9H-purin-9-yl)methyl]phenyl}acetate CHEMBL1089225
BDBM50315268 CHEMBL1093467 Ethyl{3-[(6-amino-2-butoxy-8-oxo-7,8-dihydro-9H-purin-9-yl)methyl]phenyl}acetate
BDBM50320056 ethyl 2-((S)-3-((S)-2-(2-amino-5-bromobenzamido)-3-cyclohexylpropanamido)-4-(benzyloxy)-2-oxobutanamido)acetate CHEMBL1085979
BDBM50320058 ethyl 2-(4-(benzyloxy)-3-((S)-3-cyclohexyl-2-(6-methylpyrazine-2-carboxamido)propanamido)-2-oxobutanamido)acetate CHEMBL1085980
BDBM50322731 cid_4437145 2-(2-chloro-5-(trifluoromethyl)phenylamino)-2-oxo-1-phenylethyl 2-(3-methyl-4-nitrobenzamido)acetate CHEMBL1171857
BDBM562639 Ethyl 2-(6-((2-(3-chlorophenyl)-6-cyclopropylpyrimidin-4-yl)amino)pyridin-3-yl)acetate US11401286, Example 211
CHEMBL1085974 BDBM50320051 ethyl 2-(4-(benzyloxy)-3-((S)-3-cyclohexyl-2-(3-methyl-2-nitrobenzamido)propanamido)-2-oxobutanamido)acetate
CHEMBL1089517 BDBM50315269 Methyl{3-[(6-amino-2-methoxyethoxy-8-oxo-7,8-dihydro-9H-purin-9-yl)methyl]phenyl}acetate
CHEMBL1170660 BDBM50322266 rac-Benzyl [1-butyl-2,5-dioxo-9-(4-phenoxybenzyl)-1,4,9-triazaspiro[5.5]undec-3-yl]acetate hydrochloride
CHEMBL1170773 BDBM50321789 (R)-ethyl 2-(1-benzyl-6',7'-dihydrospiro[piperidine-4,4'-thieno[3,2-c]pyran]-6'-yl)acetate
CHEMBL1288105 N4-(6-((6-amino-2-methyl-4-quinolinyl)amino)hexyl)-2-methyl-4,6-quinolinediamine acetate NSC-238146 BDBM50332200
CHEMBL372135 methyl 2-[2-oxo-1'-(1-phenylethyl)spiro[2,3-dihydro-1H-indole-3,4'-(hexahydropyridine)]-1-yl]acetate BDBM50173273
CHEMBL380580 methyl 2-[2-oxo-1'-perhydro-2-naphthalenylspiro[2,3-dihydro-1H-indole-3,4'-(hexahydropyridine)]-1-yl]acetate BDBM50173276
CHEMBL495726 (S)-1-(4-(3-(bis(4-fluorophenyl)amino)propyl)piperazin-1-yl)-3-phenylpropan-2-yl acetate BDBM50265360
CHEMBL578414 BDBM50301050 4-(3-(4-hydroxy-2-methoxy-5-(2-methylbut-3-en-2-yl)phenyl)acryloyl)phenyl acetate
CHEMBL583456 BDBM50301051 4-(3-(4-acetoxy-2-methoxy-5-(2-methylbut-3-en-2-yl)phenyl)acryloyl)phenyl acetate
Ethyl-2-((S)-3-((S)-2-amino-3-(4-hydroxyphenyl)-propanamido)-2,6-dioxopiperidin-1-yl)acetate hydrochloride BDBM50316389 CHEMBL1095913
Ethyl-2-((S)-3-((S)-2-amino-4-(methylthio)butan amido)-2,6-dioxopiperidin-1-yl)acetate hydrochloride CHEMBL1099253 BDBM50316387
Methyl 2-((1S,2R)-2-(5-carbamoyl-4-(m-tolylamino)pyrimidin-2-ylamino)cyclohexylamino)acetate US9579320, Example 203 BDBM290803
Methyl{2-[(6-amino-2-butoxy-8-oxo-7,8-dihydro-9H-purin-9-yl)methyl]phenyl}acetate BDBM50315261 CHEMBL1089220
Methyl{3-[(6-amino-2-butoxy-8-oxo-7,8-dihydro-9H-purin-9-yl)methyl]phenyl}acetate BDBM50315256 CHEMBL1089224
N-(Ethoxycarbonylmethyl)-maleimide ethyl 2-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)acetate Maleimide-Related Compound 4 BDBM7805
Pirinixic acid-based compound, 2c ethyl 2-{[4-chloro-6-(quinolin-6-ylamino)pyrimidin-2-yl]sulfanyl}acetate BDBM24554
Sodium; [4-(8-hydroxy-7,8-dihydro-6H-imidazo[4,5-d][1,3]diazepin-3-ylmethyl)-phenyl]-acetate (2.5H2O) BDBM50087376 CHEMBL39456
Step 1: Preparation of 5-bromo-6-chloro-3-((4-chlorophenyl)ethynyl)pyridin-2-yl acetate US10214534, Compound 4002 BDBM357836
US10285989, Example 205 BDBM384985 methyl ({[2-(dimethylamino)-6- oxo-1,6-dihydropyrimidin-4- yl]carbonyl}amino)[4- (trifluoromethyl)phenyl]acetate
US10975084, Example 8-7 methyl (5-methyl-7-oxo-4,7- dihydro[1,2,4]triazolo[1,5- a]pyrimidin-6-yl)acetate BDBM492405
[(1-{2-[4-(1,3-benzothiazol-2-yloxy)phenyl]ethyl}piperidin-4-yl)carbamoyl]methyl acetate Benzthiazole compound, 27o BDBM24230
[(20S)-20-(N,N-dimethylamino)-3 beta-(senecioylamino)-5 alpha-pregn-16-en-4 beta-yl acetate] CHEMBL460447 BDBM50242345
ethyl 2-(((2S,4R)-4-(5- cyclopropylisoxazole-3-carboxamido)-2- methylpiperidin-1-yl)sulfonyl)acetate BDBM432545 US10577363, Compound 245
methyl 2-(2-(methyl(5-(pyrrolidin-1-yl)pentyl)amino)-3-phenyl-3,4-dihydroquinazolin-4-yl)acetate BDBM50197239 CHEMBL245610
methyl 2-[2-oxo-1'-(3-trifluoromethylbenzyl)spiro[2,3-dihydro-1H-indole-3,4'-(hexahydropyridine)]-1-yl]acetate BDBM50173266 CHEMBL264066
methyl 2-[2-oxo-1'-(4-phenylbenzyl)spiro[2,3-dihydro-1H-indole-3,4'-(hexahydropyridine)]-1-yl]acetate BDBM50173278 CHEMBL198322
(E)-methyl 2-(4-(1H-indol-3-yl)piperidin-1-yl)-2-(1-(3-(3,4,5-trifluorophenyl)acryloyl)piperidin-4-yl)acetate CHEMBL392366 BDBM50224509 methyl 2-(4-(1H-indol-3-yl)piperidin-1-yl)-2-(1-(3-(3,4,5-trifluorophenyl)acryloyl)piperidin-4-yl)acetate
4-{[(acetylamino)carbonyl]amino}tetrahydro-3-thienyl acetate SMR000069129 [4-(ethanoylcarbamoylamino)thiolan-3-yl] ethanoate acetic acid [4-[[acetamido(oxo)methyl]amino]-3-thiolanyl] ester [4-(acetylcarbamoylamino)thiolan-3-yl] acetate cid_2832895 MLS000060901 acetic acid [4-(acetylcarbamoylamino)tetrahydrothiophen-3-yl] ester BDBM40890
CHEMBL100958 BDBM50119344 (S)-methyl 2-cyclohexyl-2-((3S,4S)-3-((4-hydroxy-4-(3-phenylpropyl)piperidin-1-yl)methyl)-4-phenylpyrrolidin-1-yl)acetate methyl 2-cyclohexyl-2-{3-[4-hydroxy-4-(3-phenylpropyl)hexahydro-1-pyridinylmethyl]-4-phenyltetrahydro-1H-1-pyrrolyl}acetate
MLS000048242 methyl {4-[(1,3-benzodioxol-5-ylamino)sulfonyl]phenoxy}acetate methyl 2-[4-(1,3-benzodioxol-5-ylsulfamoyl)phenoxy]acetate cid_1082971 BDBM40052 2-[4-(1,3-benzodioxol-5-ylsulfamoyl)phenoxy]acetic acid methyl ester methyl 2-[4-(1,3-benzodioxol-5-ylsulfamoyl)phenoxy]ethanoate SMR000073539
[4-[(2-phenylsulfanylacetyl)amino]phenyl] acetate SMR000072806 acetic acid [4-[[1-oxo-2-(phenylthio)ethyl]amino]phenyl] ester acetic acid [4-[[2-(phenylthio)acetyl]amino]phenyl] ester 4-{[2-(phenylthio)acetyl]amino}phenyl acetate MLS000063417 cid_891318 BDBM50044 [4-(2-phenylsulfanylethanoylamino)phenyl] ethanoate
cid_1005954 ethyl 2-[4-(1,3-benzodioxol-5-ylsulfamoyl)phenoxy]ethanoate ethyl {4-[(1,3-benzodioxol-5-ylamino)sulfonyl]phenoxy}acetate SMR000073906 2-[4-(1,3-benzodioxol-5-ylsulfamoyl)phenoxy]acetic acid ethyl ester BDBM41339 MLS000096682 ethyl 2-[4-(1,3-benzodioxol-5-ylsulfamoyl)phenoxy]acetate
(−)-Ethyl 2-[2-(2-benzoyl-5,6-dibromo-1H-benzo[d]imidazol-1-yl)-2 cyclopropylacetamido] acetate (Compound 21) BDBM115176
(+)-(S)-Ethyl-[2-hydroxy-2-[2-methyl-5-(4-methylsulfonyl)phenyl-1-phenyl-1H-pyrrol-3-yl]]acetate BDBM50253487 CHEMBL494700
4-((3,3-Dimethylbutoxy)carbonyloxy)benzyl 2-(1-(4-Chlorobenzoyl)-5-methoxy-2-methyl-1H-indol-3-yl)acetate CHEMBL1094722 BDBM50316978
4-(1-{[(7,7-Dimethyl-5-phenyl-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidine-3-yl)carbonyl]amino}-1-ethylpropyl)benzyl Acetate CHEMBL1688090 BDBM50339338
6-bisalkylamino-2-quinolinone, 6u ethyl 2-{[2-oxo-4-(trifluoromethyl)-1,2-dihydroquinolin-6-yl](2,2,2-trifluoroethyl)amino}acetate BDBM18596
BDBM167926 (1-(3-Chlorobenzyl)-1H-1,2,3-triazol-4-yl)methyl 2-((2-oxo-2H-chromen-4-yl)oxy)acetate (8l)
BDBM21558 Spiro-indolinone analogue, 51 ethyl 2-{1'-benzyl-5-chloro-1,2-dihydrospiro[indole-3,3'-pyrrolidine]-2,2',5'-trione}acetate
BDBM329737 US9663523, Example 1 Preparation of ethyl [6-(4-chlorophenyl)-1-methyl-4H-[1,2,4]triazolo[4,3-a][1]benzazepin-4-yl]acetate
BDBM329743 Preparation of ethyl [6-(3-chlorophenyl)-1-methyl-4H-[1,2,4]triazolo[4,3-a][1]benzazepin-4-yl]acetate US9663523, Example 7
BDBM411199 Methyl 2-(N-(4-(2-fluoro-6-methoxyphenyl)pyridin-3-yl)-2,6-bis(trifluoromethyl) isonicotinamido)acetate US10385022, Example 195
BDBM50087678 Sodium; {3-[(E)-7-(4-azido-3-iodo-phenyl)-3-hydroxy-hept-1-enyl]-1-hydroxy-cyclohexyl}-acetate CHEMBL168507
BDBM50173281 methyl 2-[1'-(1,2-dihydro-5-acenaphthylenyl)-2-oxospiro[2,3-dihydro-1H-indole-3,4'-(hexahydropyridine)]-1-yl]acetate CHEMBL198046
BDBM50204988 CHEMBL232064 methyl 2-(4-acetamido-5-((2-(2-chloroacetamido)thiazol-4-yl)methyl)-4H-1,2,4-triazol-3-ylthio)acetate
BDBM50218718 CHEMBL388435 methyl 2-(3-(3-Methoxy-4-nitrophenyl)-11-oxo-10,11-dihydrodibenzo[b,f][1,4]oxazepin-8-yl)acetate
BDBM50253312 CHEMBL494715 Ethyl 4-{2-[(4-carbamimidoylphenoxy)methyl]-2,4-dimethyl-3,4-dihydro-2H-1,4-benzoxazin-7-ylamino}-4-oxobutanoate acetate
BDBM50253488 CHEMBL494904 (-)-(R)-Ethyl-[2-hydroxy-2-[2-methyl-5-(4-methylsulfonyl)phenyl-1-phenyl-1H-pyrrol-3-yl]]acetate
BDBM50253567 (+)-(S)-Ethyl-[2-ethoxy-2-[-2-methyl-5-(4-methylsulfonyl)phenyl-1-phenyl-1H-pyrrol-3-yl]]acetate CHEMBL493492
BDBM50253568 CHEMBL523515 (-)-(R)-Ethyl-[2-ethoxy-2-[-2-methyl-5-(4-methylsulfonyl)phenyl-1-phenyl-1H-pyrrol-3-yl]]acetate
BDBM50296512 Trifluoro-acetate(2R,3R)-3-(2,4,5-trifluoro-phenyl)-1,2,3,4-tetrahydro-benzo[4,5]imidazo[1,2-a]pyridin-2-yl-ammonium CHEMBL549913
BDBM50315267 CHEMBL1093466 Methyl{5-[(6-amino-2-butoxy-8-oxo-7,8-dihydro-9H-purin-9-yl)methyl]-2-fluorophenyl}acetate
BDBM50332819 (8R,9S,10S,13S,14S)-10,13-dimethyl-17-oxo-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[alpha]phenanthren-4-yl acetate CHEMBL1630269
BDBM50339339 CHEMBL1688091 4-(1-{[(7,7-Dimethyl-5-phenyl-4,5,6,7-tetrahydropyrazolo[1,5-a]-pyrimidine-3-yl)carbonyl]-amino}-1-ethylpropyl)phenyl Acetate
BDBM50343394 methyl 2-(2-(4-fluorophenyl)-8-methyl-4H-benzo[b]imidazo[1,2-d][1,4]oxazin-4-yl)acetate CHEMBL1774935
BDBM50344582 2-(3-methyl-5-(N-(6-methyl-4-(trifluoromethyl)pyridin-2-ylcarbamoyl)sulfamoyl)thiophen-2-yl)ethyl acetate CHEMBL1778559
BDBM526341 US11186554, Compound 90 ethyl 2-(5-methyl-4-(2-((3- (trifluoromethyl)phenyl)amino)phenyl)-1H- pyrazol-1-yl)acetate
BDBM549522 US11304929, Example 01-030 methyl 2-(4-{[(4-chloro-1,6-dimethyl-1H-indol-2- yl)formamido]methyl}benzenesulfonyl)acetate
BDBM561957 ethyl 2-[6-[(E)-2-(aminomethyl)-3-fluoro-allyloxy]-1-oxo-3,4-dihydro isoquinolin-2-yl]acetate US11396495, No. 12
BDBM561958 US11396495, No. 13 ethyl 2-[6-[(Z)-2-(aminomethyl)-3-fluoro-allyloxy]-1-oxo-3,4-dihydro isoquinolin-2-yl]acetate
CHEMBL1085978 ethyl 2-(4-(benzyloxy)-3-((S)-2-(5-bromo-2-(tert-butoxycarbonylamino)benzamido)-3-cyclohexylpropanamido)-2-oxobutanamido)acetate BDBM50320055
CHEMBL1085982 ethyl 2-(4-(benzyloxy)-3-((S)-3-cyclohexyl-2-(2-(naphthalen-1-yl)acetamido)propanamido)-2-oxobutanamido)acetate BDBM50320060
CHEMBL1092654 Methyl{5-[(6-amino-2-butoxy-8-oxo-7,8-dihydro-9H-purin-9-yl)methyl]-2-methoxyphenyl}acetate BDBM50315265
CHEMBL1092655 Methyl{3-[(6-amino-2-butoxy-8-oxo-7,8-dihydro-9H-purin-9-yl)methyl]-4-methoxyphenyl}acetate BDBM50315266
CHEMBL1270883 BDBM50329114 ethyl 2-(6-(4,6-di(pyrrolidin-1-yl)-1,3,5-triazin-2-ylamino)benzo[d]thiazol-2-ylthio)acetate
CHEMBL1630264 BDBM50332814 (8R,9S,10R,13S,14S)-10,13-dimethyl-17-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[alpha]phenanthren-4-yl acetate
CHEMBL1630270 BDBM50332820 (8R,9S,10R,13S,14S)-10,13-dimethyl-17-oxo-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[alpha]phenanthren-4-yl acetate
CHEMBL1668042 (S)-methyl 2-((5-hydroxy-12b-methyl-3,6,8,11-tetraoxo-1,2,3,12b-tetrahydrotetraphen-4(6H,8H,11H)-ylidene)methylamino)acetate BDBM50336354
CHEMBL1683487 ethyl 2-(4-((3-((R)-3-amino-4-(2,4,5-trifluorophenyl)butanoyl)thiazolidine-2-carboxamido)methyl)phenoxy)acetate hydrochloride BDBM50337768
CHEMBL1683489 BDBM50337770 ethyl 2-(3-((3-((R)-3-amino-4-(2,4,5-trifluorophenyl)butanoyl)thiazolidine-2-carboxamido)methyl)phenoxy)acetate hydrochloride
CHEMBL202144 ethyl 2-(3-(4-(4-(1,1,1,3,3,3-hexafluoro-2-hydroxypropan-2-yl)phenyl)-5-methylisoxazol-3-yl)ureido)acetate BDBM50176188
CHEMBL459318 Ethyl 2-(N-{2-[(4-carbamimidoylphenoxy)methyl]-2,4-dimethyl-3,4-dihydro-2H-1,4-benzoxazin-7-yl}benzamido)acetate BDBM50253932
CHEMBL488350 BDBM50270583 methyl 2-((5-(4-(4-(benzyloxy)phenylamino)pyrido[3,4-d]pyrimidin-6-yl)furan-2-yl)methylamino)acetate
CHEMBL517875 BDBM50253780 Ethyl 2-(benzyl{2-[(4-carbamimidoylphenoxy)methyl]-2,4-dimethyl-3,4-dihydro-2H-1,4-benzoxazin-7-yl}amino)acetate
CHEMBL523155 BDBM50249884 [2-(Hydroxymethyl)-4-(methylethylidene)-5-oxo-2-2,3-dihydrofuryl]methyl 2-(4-[2-(4-Methylphenyl)ethynyl]phenoxy)acetate
CHEMBL563339 Trifluoro-acetate(S)-3-{(R)-3-[(4-bromo-phenyl)-hydroxy-carbamoyl]-1-carboxyaminocarbonyl-propylcarbamoyl}-1-carboxy-propyl-ammonium BDBM50294135
CHEMBL595397 BDBM50305162 Methyl 2-{8,12,14-triazatetracyclo[8.6.1.0^{2,7}.0^{13,17}]heptadeca-1(17),2(7),3,5,10,13,15-heptaen-9-yl}acetate
CHEMBL604053 BDBM50305715 2-(4-(6-(2,4-difluorophenylthio)-[1,2,4]triazolo[4,3-a]pyridin-3-yl)piperidin-1-yl)-2-oxoethyl acetate hydrochloride
Cancer Chemotherapy National Service Center (CCNSC) compound 112500 1,8a-dihydroxy-4a,5,6-trimethyl-decahydronaphthalen-2-yl acetate BDBM507 NSC 112500
Ethyl 2-(benzyl{2-[(4-carbamimidoylphenoxy)methyl]-2,4-dimethyl-3,4-dihydro-2H-1,4-benzoxazin-6-yl}amino)acetate BDBM50253816 CHEMBL460143
Ethyl [2-(1-{[(4- Bromophenyl)carbamoyl] amino}ethyl)-1H- imidazol-1-yl]acetate US10800744, Number 12 BDBM391967 US10301269, Number 12
Ethyl [2-(1-{[(4- Bromophenyl)carbamoyl] amino}propyl)-1H- imidazol-1-yl]acetate US10800744, Number 7 US10301269, Number 7 BDBM391962
Indomethacin derivative, 5 BDBM22952 CHEMBL73572 methyl 2-{1-[(4-chlorophenyl)carbonyl]-5-methoxy-2-methyl-1H-indol-3-yl}acetate
Methyl 2-(N-(2-methoxy-3,4′-bipyridin-3′-yl)-2,6-bis(trifluoromethyl)isonicotinamido)acetate BDBM411186 US10385022, Example 182
Sodium [2'-[(cyclopropanecarbonyl-ethyl-amino)-methyl]-4'-(6-ethoxy-pyridin-3-yl)-6-methoxy-biphenyl-3-yl]-acetate BDBM50335954 CHEMBL1668898
US10188615, Example 173 (1,2-Trans)-2-((3-((R)-3-Amino-1-Hydroxypropyl)Phenoxy)Methyl)Cyclohexyl Acetate US10639286, Example 173 BDBM323490
US10188615, Example 174 US10639286, Example 174 (1,2-Cis)-2-((3-((R)-3-Amino-1-Hydroxypropyl)Phenoxy)Methyl)Cyclohexyl Acetate BDBM323491
US10799518, Compound 72 methyl{[(2S)-2-{[(4- bromophenyl)carbamoyl]amino} pentanoyl]amino}acetate US10434112, Compound 72 BDBM350610 US10208071, Compound 72
US9579320, Example 187 tert-butyl 2-(3-(2-((1R,2S)-2-aminocyclohexylamino)-5-carbamoylpyrimidin-4-ylamino)phenoxy)acetate (Racemate) BDBM290788
US9796708, Example 1061 methyl {4-[4-(2-methoxyphenyl)-1H-pyrrolo[2,3-b]pyridin-2-yl]piperidin-1-yl}acetate BDBM353829
ethyl 2-(4-{[(4-chloro-1,6-dimethyl-1H-indol-2- yl)formamido]methyl}benzenesulfonyl)acetate BDBM549520 US11304929, Example 01-032
methyl 2-(2-(8-(4-cyclohexylbenzoyl)-4-oxo-1-phenyl-1,3,8-triazaspiro[4.5]decan-3-yl)acetamido)acetate CHEMBL1631040 BDBM50332422
methyl 2-[1'-[4-(tert-butyl)cyclohexylmethyl]-2-oxospiro[2,3-dihydro-1H-indole-3,4'-(hexahydropyridine)]-1-yl]acetate CHEMBL197942 BDBM50173264
methyl 2-[6-[(E)-2-(aminomethyl)-3-fluoro-allyloxy]-1-oxo-3,4-dihydro isoquinolin-2-yl]acetate BDBM561981 US11396495, No. 58
methyl 2-[6-[(Z)-2-(aminomethyl)-3-fluoro-allyloxy]-1-oxo-3,4-dihydro isoquinolin-2-yl]acetate BDBM561982 US11396495, No. 59
methyl 2-cyclohexyl-2-[(2-acetamido-1,3-thiazol-5-yl)sulfanyl]acetate 2-amino-5-thio-substituted thiazole 74 BDBM5706
process for preparing methyl 2-(2-{2-[1-(2-fluorophenyl)-1h-1,2,3,4-tetrazol-5-yl]phenyl}phenoxy)acetate US9556132, 8 BDBM205044
BDBM90300 methyl 2-[4-(3-methylbutylcarbamothioylamino)phenyl]acetate cid_899587 methyl (4-{[(isopentylamino)carbothioyl]amino}phenyl)acetate 2-[4-[[(3-methylbutylamino)-sulfanylidenemethyl]amino]phenyl]acetic acid methyl ester MLS000702610 2-[4-(isoamylthiocarbamoylamino)phenyl]acetic acid methyl ester methyl 2-[4-(3-methylbutylcarbamothioylamino)phenyl]ethanoate SMR000226828
acetic acid [2-methoxy-4-[(2,4,6-trimethylphenyl)iminomethyl]phenyl] ester 4-[(mesitylimino)methyl]-2-methoxyphenyl acetate cid_691624 BDBM90291 acetic acid [4-(mesityliminomethyl)-2-methoxy-phenyl] ester [2-methoxy-4-[(2,4,6-trimethylphenyl)iminomethyl]phenyl] ethanoate MLS000700091 [2-methoxy-4-[(2,4,6-trimethylphenyl)iminomethyl]phenyl] acetate SMR000225582
ethyl 2-(2-oxidanylidenequinoxalin-1-yl)ethanoate SMR000126418 ethyl 2-(2-oxoquinoxalin-1-yl)acetate ethyl 2-(3-oxo-3,4-dihydro-4-quinolinyl)acetate 2-(2-oxo-1-quinoxalinyl)acetic acid ethyl ester MLS000541560 2-(2-ketoquinoxalin-1-yl)acetic acid ethyl ester BDBM55385 cid_3727805
(rac)-Ethyl 2-[4-[3-fluoro-4-(trifluoromethyl)phenyl]-6,7-dihydro-5H-cyclopenta[c]pyridin-5-yl]acetate BDBM325737 US9636338, 11
1-(1,2-dihydroacenaphthylen-1-yl)-4-(1-methyl-1H-pyrrolo[2,3-b]pyridin-3-yl)piperidin-3-yl acetate BDBM50185801 CHEMBL212571
2-{6-amino-8-[(7-chloro-1,3-benzothiazol-2-yl)sulfanyl]-9H-purin-9-yl}ethyl acetate BDBM20768 Benzothiazole analogue, 21
4-{6-amino-8-[(7-chloro-1,3-benzothiazol-2-yl)sulfanyl]-9H-purin-9-yl}butyl acetate BDBM20770 Benzothiazole analogue, 23
5-methoxy-4-(3-(4-methoxyphenyl)-3-oxoprop-1-enyl)-2-(2-methylbut-3-en-2-yl)phenyl acetate CHEMBL569456 BDBM50301054
BDBM12417 copper(2+) ion 2-{2-carboxylato-12-[(4-sulfamoylphenyl)formamido]-1,7,10-trioxa-4-azadodec-1-en-4-yl}acetate BR17
BDBM20769 Benzothiazole analogue, 22 3-{6-amino-8-[(7-chloro-1,3-benzothiazol-2-yl)sulfanyl]-9H-purin-9-yl}propyl acetate
BDBM223150 Ethyl 2-(4-(4-(2-(ethyl(m-tolyl)amino)-2-oxoethyl)-4H-thieno[3,2-b]pyrrole-5carboxamido)phenyl)acetate (12)
BDBM22955 4-methoxyphenyl 2-{1-[(4-chlorophenyl)carbonyl]-5-methoxy-2-methyl-1H-indol-3-yl}acetate CHEMBL316866 Indomethacin derivative, 8
BDBM22958 CHEMBL318881 Indomethacin derivative, 11 4-fluorophenyl 2-{1-[(4-chlorophenyl)carbonyl]-5-methoxy-2-methyl-1H-indol-3-yl}acetate
BDBM22967 Indomethacin derivative, 20 CHEMBL95643 2-phenylethyl 2-{1-[(4-chlorophenyl)carbonyl]-5-methoxy-2-methyl-1H-indol-3-yl}acetate
BDBM22969 CHEMBL316484 2-phenylethyl 2-{1-[(4-bromophenyl)methyl]-5-methoxy-2-methyl-1H-indol-3-yl}acetate Indomethacin derivative, 22
BDBM325751 (rac)-Ethyl 2-[4-[3-fluoro-4-(trifluoromethyl)phenyl]-6,7-dihydro-5H-cyclopenta[c]pyridin-7-yl]acetate US9636339, 1
BDBM373268 (3S,5S)-1-([1,1′-biphenyl]-2-carbonyl)-5-((quinoline-8-carboxamido)methyl)pyrrolidin-3-yl acetate US9896452, Example 131
BDBM391963 US10800744, Number 8 US10301269, Number 8 Ethyl {2-[(1S)-1-{[(4- bromophenyl)carbamoyl] amino}butyl]-1H- imidazol-1-yl}acetate
BDBM401509 2-(6-carbmoyl-2-(4-(2- ((diethylamino)methyl)-4- (trifluoromethyl)phenoxy)phenyl) pyrimidin-4-yl)ethyl acetate US10005768, Compound 124
BDBM50001348 CHEMBL130695 methyl 2-[2-hydroxy-7,7-dimethyl-1-spiro[1H-indene-1,4'-(hexahydropyridine)]-1-ylsulfonylmethylbicyclo[2.2.1]hept-2-yl]acetate
BDBM50206190 CHEMBL392970 (E)-3-((6,7-dimethoxy-3,4-dihydroisoquinolin-2(1H)-yl)methyleneamino)-6,7,8,9-tetrahydro-5H-benzo[7]annulen-5-yl acetate
BDBM50253321 Methyl 2-(4-(4-Fluorophenyl)-5-(2-(3-methylbutan-2-ylamino)pyridin-4-yl)-1H-imidazol-2-ylthio)acetate CHEMBL492295
BDBM50253489 CHEMBL494905 (+/-)-Ethyl-[2-hydroxy-2-[1-(3-fluoro)phenyl-2-methyl-5-(4-methylsulfonyl)phenyl-1H-pyrrol-3-yl]]acetate
BDBM50253542 CHEMBL523388 (+/-)-Ethyl-[2-hydroxy-2-[1-(4-methoxy)phenyl-2-methyl-5-(4-methylsulfonyl)phenyl-1H-pyrrol-3-yl]]acetate
BDBM50253601 CHEMBL493297 Ethyl-[2-ethoxy-2-[1-(4-methoxy)phenyl-2-methyl-5-(4-methylsulfonyl)phenyl-1H-pyrrol-3-yl]]acetate
BDBM50258494 1,3-bis(nitrooxy)propan-2-yl 2-(1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1H-indol-3-yl)acetate CHEMBL466447
BDBM50316977 CHEMBL1094723 4-((2-(Trimethylsilyl)ethoxy)carbonyloxy)benzyl 2-(1-(4-Chlorobenzoyl)-5-methoxy-2-methyl-1H-indol-3-yl)acetate
BDBM50332397 CHEMBL1629905 2,2,6,6-tetramethylpiperidin-4-yl 2-(8-(4-cyclohexylbenzoyl)-4-oxo-1-phenyl-1,3,8-triazaspiro[4.5]decan-3-yl)acetate
BDBM50344579 2-(5-(N-(6-amino-5-fluoro-4-(trifluoromethyl)pyridin-2-ylcarbamoyl)sulfamoyl)-3-methylthiophen-2-yl)ethyl acetate CHEMBL1778556
CHEMBL1085983 ethyl 2-(4-(benzyloxy)-3-((S)-3-cyclohexyl-2-(1-methyl-1H-indole-2-carboxamido)propanamido)-2-oxobutanamido)acetate BDBM50320061
CHEMBL1098916 Ethyl-2-((S)-3-((S)-2-amino-3-(1H-imidazol-4-yl)-propanamido)-2,6-dioxopiperidin-1-yl)acetate hydrochloride BDBM50316386
CHEMBL1099254 BDBM50316388 Ethyl-2-((S)-3-((S)-2-amino-3-(1H-indol-3-yl)propanamido)-2,6-dioxopiperidin-1-yl)acetate hydrochloride
CHEMBL1629878 BDBM50332402 methyl 2-(2-(8-(4-tert-butylbenzoyl)-4-oxo-1-phenyl-1,3,8-triazaspiro[4.5]decan-3-yl)acetamido)acetate
CHEMBL1770535 (E)-ethyl 2-(4-chloro-2-oxo-3-(2-oxo-2-(pyridin-3-yl)ethylidene)indolin-1-yl)acetate BDBM50342595
CHEMBL198829 methyl 2-[2-oxo-1'-(4-oxo-4-phenylbutanoyl)spiro[2,3-dihydro-1H-indole-3,4'-(hexahydropyridine)]-1-yl]acetate BDBM50173285
CHEMBL290157 Sodium; {3-[2-(8-hydroxy-7,8-dihydro-6H-imidazo[4,5-d][1,3]diazepin-3-yl)-ethyl]-phenyl}-acetate (0.8H2O) BDBM50087368
CHEMBL370226 BDBM50173272 methyl 2-[2-oxo-1'-(1,2,3,4-tetrahydro-2-naphthalenyl)spiro[2,3-dihydro-1H-indole-3,4'-(hexahydropyridine)]-1-yl]acetate
CHEMBL429819 BDBM50218706 methyl [3-(3-methoxy-4-nitrophenyl)-11-oxo-10,11-dihydro-5H-dibenzo[b,e][1,4]diazepin-8-yl]acetate
CHEMBL461192 Ethyl 2-[2-(4-carbamimidoylbenzyloxy)-4-methyl-3-oxo-N-phenyl-3,4-dihydro-2H-1,4-benzoxazine-7-carbonylamino]acetate BDBM50253718
CHEMBL493493 (+/-)-Ethyl-[2-ethoxy-2-[1-(3-fluoro)phenyl-2-methyl-5-(4-methylsulfonyl)phenyl-1H-pyrrol-3-yl]]acetate BDBM50253569
CHEMBL571205 4-(3-(4-hydroxyphenyl)-3-oxoprop-1-enyl)-5-methoxy-2-(2-methylbut-3-en-2-yl)phenyl acetate BDBM50301053
US10189859, Compound 197 methyl 2-(2-(2-((5-amino-6-(2,3-dichlorophenyl)-1,2,4-triazin-3-yl)amino)ethoxy)ethoxy)acetate BDBM331949
US10265310, Example 21 BDBM377275 rac-trans-methyl 2-(5-(3-(4-chlorophenyl)ureido)-4-(4-methoxyphenyl)-2-oxopiperidin-1-yl)acetate
US10336721, ISO-1 US8618147, ISO-1 CHEMBL210858 BDBM50186426 US10968198, ISO-1 methyl 2-(3-(4-hydroxyphenyl)-4,5-dihydroisoxazol-5-yl)acetate
US10336739, Example 96 BDBM406503 ethyl 2-{5-[6-butyl- 5-(2,6- dimethoxyphenyl)- 2,4- dihydroxypyridin- 3-yl]-1,3,4- oxadiazol-2- yl}acetate
US10538497, Example 22 BDBM429819 Methyl (Z)-2-((4-(N-(3-bromo- 4-fluorophenyl)-N'- hydroxycarbamimidoyl)-1,2,5- oxadiazol-3-yl)thio)acetate
US10800744, Number 15 Ethyl {2-[1-({[4- (trifluoromethyl)phenyl] carbamoyl} amino)propyl]-1H- imidazol-1-yl}acetate US10301269, Number 15 BDBM391970
US10981879, Example 50 BDBM492758 methyl 2-((5-amino-3H- [1,2,3]triazolo[4,5-b]pyridin- 7-yl)thio)-2-(2- chlorophenyl)acetate
US11186554, Compound 162 [1-acetyl-3-[[5-[2-[4- (trifluoromethyl)anilino]phenyl]tetrazol-2- yl]methyl]azetidin-3-yl]acetate BDBM526390
US11401286, Example 35 methyl 2-(4-((4-chloro-6-(5-chlorothiophen-2-yl)-1,3,5-triazin-2-yl)amino)phenyl)acetate BDBM562466
US9663523, Example 8 Preparation of tert-butyl [6-(4-chlorophenyl)-1-methyl-4H-[1,2,4]triazolo[4,3-a][1]benzazepin-4-yl]acetate BDBM329744
indole derivative, 23 tert-butyl 2-[2-(2-benzenesulfonamido-2,3-dihydro-1H-inden-5-yl)-1H-indol-1-yl]acetate BDBM27301
methyl 2-((4-(1-(3-fluorobenzyl)-1H-indazol-5-ylamino)pyrrolo[1,2-f][1,2,4]triazin-5-yl)methoxy)acetate BDBM50204123 CHEMBL246491
methyl 2-((S)-2-(2-(3-(diphenylcarbamoyl)-5-methyl-1H-pyrazol-1-yl)benzoyl)-1,2,3,4-tetrahydroisoquinolin-3-yl)acetate BDBM50254529 CHEMBL453466
methyl 2-[2-oxo-1'-[2-(3-thienyl)benzyl]spiro[2,3-dihydro-1H-indole-3,4'-(hexahydropyridine)]-1-yl]acetate BDBM50173257 CHEMBL372779
2-[2-[(Z)-2-nitrovinyl]phenoxy]acetic acid ethyl ester cid_5286552 MLS000586023 SMR000204386 2-[2-[(Z)-2-nitroethenyl]phenoxy]acetic acid ethyl ester ethyl 2-[2-[(Z)-2-nitroethenyl]phenoxy]acetate ethyl 2-[2-[(Z)-2-nitroethenyl]phenoxy]ethanoate ethyl {2-[(Z)-2-nitrovinyl]phenoxy}acetate BDBM63203
2-[4-(3-hydroxypropylthiocarbamoylamino)phenyl]acetic acid methyl ester 2-[4-[[(3-hydroxypropylamino)-sulfanylidenemethyl]amino]phenyl]acetic acid methyl ester methyl 2-[4-(3-hydroxypropylcarbamothioylamino)phenyl]acetate methyl [4-({[(3-hydroxypropyl)amino]carbothioyl}amino)phenyl]acetate methyl 2-[4-(3-oxidanylpropylcarbamothioylamino)phenyl]ethanoate SMR000164010 BDBM94464 MLS000325001 cid_1825554
2-[4-(4-pyridylmethylsulfamoyl)phenoxy]acetic acid ethyl ester MLS000096632 ethyl (4-{[(4-pyridinylmethyl)amino]sulfonyl}phenoxy)acetate BDBM42040 SMR000073796 ethyl 2-[4-(pyridin-4-ylmethylsulfamoyl)phenoxy]acetate ethyl 2-[4-(pyridin-4-ylmethylsulfamoyl)phenoxy]ethanoate cid_1082996 2-[4-(pyridin-4-ylmethylsulfamoyl)phenoxy]acetic acid ethyl ester
BDBM59804 SMR000125298 2-[(1-phenyl-1,2,4-triazol-3-yl)oxy]acetic acid ethyl ester MLS000539840 cid_1486530 ethyl 2-[(1-phenyl-1,2,4-triazol-3-yl)oxy]ethanoate ethyl 2-[(1-phenyl-1,2,4-triazol-3-yl)oxy]acetate ethyl 2-[(1-phenyl-1H-1,2,4-triazol-3-yl)oxy]acetate
BDBM83527 ethyl 2-cyano-2-[(2,5-dimethoxyphenyl)hydrazinylidene]acetate 2-cyano-2-[(2,5-dimethoxyphenyl)hydrazinylidene]acetic acid ethyl ester ethyl cyano[(2,5-dimethoxyphenyl)hydrazono]acetate 2-cyano-2-[(2,5-dimethoxyphenyl)hydrazono]acetic acid ethyl ester SMR000185912 ethyl 2-cyano-2-[(2,5-dimethoxyphenyl)hydrazinylidene]ethanoate cid_867281 MLS000576528
MLS001196790 [3-(4-methoxyphenyl)carbonyl-1-benzofuran-5-yl] ethanoate acetic acid [3-[(4-methoxyphenyl)-oxomethyl]-5-benzofuranyl] ester BDBM69827 [3-(4-methoxybenzoyl)-1-benzofuran-5-yl] acetate 3-(4-methoxybenzoyl)-1-benzofuran-5-yl acetate acetic acid (3-p-anisoylbenzofuran-5-yl) ester SMR000555952 cid_868434
[3-(2,5-dimethoxybenzoyl)-1-benzofuran-5-yl] acetate [3-(2,5-dimethoxyphenyl)carbonyl-1-benzofuran-5-yl] ethanoate 3-(2,5-dimethoxybenzoyl)-1-benzofuran-5-yl acetate MLS000702482 BDBM69064 cid_867287 acetic acid [3-(2,5-dimethoxybenzoyl)benzofuran-5-yl] ester SMR000226432 acetic acid [3-[(2,5-dimethoxyphenyl)-oxomethyl]-5-benzofuranyl] ester
ethyl 2-(5-methyl-1,2,3,4-tetrazol-1-yl)ethanoate BDBM43444 ethyl 2-(5-methyltetrazol-1-yl)acetate ethyl (5-methyl-1H-tetrazol-1-yl)acetate SMR000307376 2-(5-methyl-1-tetrazolyl)acetic acid ethyl ester 2-(5-methyltetrazol-1-yl)acetic acid ethyl ester MLS000729098 cid_1505264
sodium;2-[4-oxo-2-[(2E)-2-[(E)-3-phenylprop-2-enylidene]hydrazinyl]-1,3-thiazol-5-yl]acetate BDBM95372 sodium;2-[4-keto-2-[(N'E)-N'-[(E)-3-phenylprop-2-enylidene]hydrazino]-2-thiazolin-5-yl]acetate SMR000236709 sodium;2-[4-oxidanylidene-2-[(2E)-2-[(E)-3-phenylprop-2-enylidene]hydrazinyl]-1,3-thiazol-5-yl]ethanoate MLS000722032 cid_16428461 sodium;2-[4-oxo-2-[(2E)-2-[(E)-3-phenylprop-2-enylidene]hydrazinyl]-5-thiazolyl]acetate
(+)-(S)-Ethyl-[2-ethoxy-2-[1-(4-methoxy)phenyl-2-methyl-5-(4-methylsulfonyl)phenyl-1H-pyrrol-3-yl]]acetate CHEMBL493497 BDBM50253602
(+)-(S)-Ethyl-[2-hydroxy-2-[1-(3-fluoro)phenyl-2-methyl-5-(4-methylsulfonyl)phenyl-1H-pyrrol-3-yl]]acetate BDBM50253490 CHEMBL493898
(-)-(R)-Ethyl-[2-hydroxy-2-[1-(3-fluoro)phenyl-2-methyl-5-(4-methylsulfonyl)phenyl-1H-pyrrol-3-yl]]acetate BDBM50253541 CHEMBL492868
(1R,2S)-1-(3,6-diethyl-5-(4-methylpyridin-2-yloxy)pyrazin-2-ylamino)-2,3-dihydro-1H-inden-2-yl acetate CHEMBL251034 BDBM50223016
(2,3-Diphenyl-3,4-dihydro-quinazolin-4-yl)-acetic acid methyl ester BDBM50148174 CHEMBL322356 methyl 2-(2,3-diphenyl-3,4-dihydroquinazolin-4-yl)acetate
2‐[6‐(4‐Chlorophenyl)‐7H‐[1,2,4]triazolo[3,4‐b][1,3,4]thiadiazin‐7‐yl]acetate (21) BDBM163662
2-(5H-imidazo[5,1-a]isoindol-5-yl)ethyl 2- (((1R,2R,5S)-2-isopropyl-5- methylcyclohexyl)oxy)acetate BDBM370426 US10233190, Example 1288
BDBM17863 Amino-Alcohol Inhibitor, 12 methyl 2-[(2S)-2-[(2S,3R)-3-amino-2-hydroxy-3-[4-(trifluoromethyl)phenyl]propanamido]propanamido]acetate
BDBM22956 4-(methylsulfanyl)phenyl 2-{1-[(4-chlorophenyl)carbonyl]-5-methoxy-2-methyl-1H-indol-3-yl}acetate CHEMBL96057 Indomethacin derivative, 9
BDBM2471 Pyrrolobenzothiadiazepine (PBTD) 10l ethyl 2-(2,2,8-trioxo-2-thia-3,9-diazatricyclo[8.4.0.0^{3,7}]tetradeca-1(10),4,6,11,13-pentaen-9-yl)acetate
BDBM267510 US9718828, Example, 39 (trans)-4-(8-amino-1-(4-(5-ethylthiazol-2-ylcarbamoyl)phenyl)imidazo [1,5-a]pyrazin-3-yl)cyclohexyl acetate
BDBM329738 Preparation of ethyl (−)-(4R)-[6-(4-chlorophenyl)-1-methyl-4H-[1,2,4]triazolo[4,3-a][1]benzazepin-4-yl]acetate US9663523, Example 2
BDBM331956 methyl 2-((2-(2-((5-amino-6-(2,3-dichlorophenyl)-1,2,4-triazin-3-yl)amino)ethoxy)ethyl)amino)acetate US10189859, Compound 199
BDBM413418 US10407431, Example 5 methyl 2-(3-((2-amino-4-(pentylamino)-5H-pyrrolo[3,2-d]pyrimidin-5-yl)methyl)-4-methoxyphenyl)acetate
BDBM450500 US10676446, Example 93 Methyl 2-[4-[3-[2-[(3,4-dichlorophenyl)methylamino]-2-oxoethyl]-4-oxoquinazolin-6-yl]piperazin-1-yl]acetate
BDBM50179742 CHEMBL206571 (3S)-3-((S)-4-methyl-2-((S)-4-methyl-2-(10H-phenothiazine-2-carboxamido)pentanamido)pentanamido)-tetrahydrofuran-2-yl acetate
BDBM50247891 Leuprorelin Viadur Lupron Depot Ped Lupron Depot ABBOTT-43818 Carcinil CHEBI:63597 Lupron Depot-Ped TAP-144 Eligard Leuprolide Acetate Lupron
BDBM50253544 CHEMBL505448 (-)-(R)-Ethyl-[2-hydroxy-2-[1-(4-methoxy)phenyl-2-methyl-5-(4-methylsulfonyl)phenyl-1H-pyrrol-3-yl]]acetate
BDBM50253600 CHEMBL522333 (-)-(R)-Ethyl-[2-ethoxy-2-[1-(3-fluoro)phenyl-2-methyl-5-(4-methylsulfonyl)phenyl-1H-pyrrol-3-yl]]acetate
BDBM562529 Methyl 2-(3-((2-(3-chlorophenyl)-6,7-dihydro-5H-cyclopenta[b]pyridin-4-yl)amino)phenyl)acetate hydrochloride US11401286, Example 100
CHEMBL1085973 BDBM50320050 ethyl 2-(4-(benzyloxy)-3-((S)-3-cyclohexyl-2-(4-oxo-4-(pyren-1-yl)butanamido)propanamido)-2-oxobutanamido)acetate
CHEMBL204787 BDBM50181233 ethyl 2-(3-(3-(1H-imidazol-1-yl)propyl)-5-methyl-5-(naphthalen-1-yl)-2,4-dioxoimidazolidin-1-yl)acetate
CHEMBL215959 methyl 2-(4-(2-((2-chloro-4-(1,1,1,3,3,3-hexafluoro-2-hydroxypropan-2-yl)phenyl)(ethyl)amino)-2-phenylethoxy)phenyl)acetate BDBM50192154
CHEMBL462272 (-)-(R)-Ethyl-[2-ethoxy-2-[1-(4-methoxy)phenyl-2-methyl-5-(4-methylsulfonyl)phenyl-1H-pyrrol-3-yl]]acetate BDBM50253627
CHEMBL495318 BDBM50253543 (+)-(S)-Ethyl-[2-hydroxy-2-[1-(4-methoxy)phenyl-2-methyl-5-(4-methylsulfonyl)phenyl-1H-pyrrol-3-yl]]acetate
CHEMBL523551 BDBM50253599 (+)-(S)-Ethyl-[2-ethoxy-2-[1-(3-fluoro)phenyl-2-methyl-5-(4-methylsulfonyl)phenyl-1H-pyrrol-3-yl]]acetate
CHEMBL95625 Indomethacin derivative, 10 BDBM22957 2-(methylsulfanyl)phenyl 2-{1-[(4-chlorophenyl)carbonyl]-5-methoxy-2-methyl-1H-indol-3-yl}acetate
CHEMBL96954 pyridin-3-yl 2-{1-[(4-chlorophenyl)carbonyl]-5-methoxy-2-methyl-1H-indol-3-yl}acetate Indomethacin derivative, 12 BDBM22959
ethyl 2-(3-(3-(1H-imidazol-4-yl)propyl)-5-methyl-5-(naphthalen-1-yl)-2,4-dioxoimidazolidin-1-yl)acetate CHEMBL380973 BDBM50181253
tert-butyl 2-{5-[6- butyl-5-(2,6- dimethoxyphenyl)- 2,4- dihydroxypyridin- 3-yl]-1,3,4- oxadiazol-2- yl}acetate BDBM406524 US10336739, Example 118